Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships by Molina-Montes, Esther et al.
For Peer Review
Pancreatic cancer risk in relation to lifetime smoking 
patterns, tobacco type, and dose-response relationships
Journal: Annals of Oncology
Manuscript ID Draft
Manuscript Type: Original Article
Date Submitted by the 
Author: n/a
Complete List of Authors: Molina, Esther; Spanish National Cancer Research Centre, Genetic and 
Molecular Epidemiology
Van Hoogstraten, Lisa; Spanish National Cancer Research Centre, 
Genetic and Molecular Epidemiology
Gomez, Paulina; Spanish National Cancer Research Centre, Genetic and 
Molecular Epidemiology
Lohr, Matthias; CLINTEC, Karolinska Institutet at Karolinska University 
Hospital, Gastrocentrum, K53
Sharp, Linda; Newcastle University, Institute of Health and Society
Molero, Xavier; Hospital Vall d'Hebron, Exocrine Pancreas Research Unit 
and Vall d'Hebron Research Institute (VHIR); Universitat Autonoma de 
Barcelona, Campus de la UAB; Centro de Investigación Biomédica en 
Red, Enfermedades Hepáticas y Digestivas
Marquez, Mirari; Spanish National Cancer Research Centre, Genetic and 
Molecular Epidemiology
Michalski, Christoph ; Martin Luther University Halle Wittenberg, 
Department of Visceral, Vascular and Endocrine Surgery
Farré, Antoni; Hospital de la Santa Creu i Sant Pau, Gastroenterology
PEREA, JOSE; 12 DE OCTUBRE UNIVERSITY HOSPITAL, SURGERY 
DEPARTMENT
O'Rorke, Michael; Queen's University Belfast , Centre for Public Helath 
Greenhalf, William; Royal Liverpool University Hospital,  Department of 
Molecular and Clinical Cancer Medicine
Ilzarbe, Lucas; Hospital del Mar, Department of Gastroenterology
Tardón, Adonina; Instituto Universitario de Oncología del Principado de 
Asturias, Department of Medicine; Centro de Investigación Biomédica en 
Red, Epidemiología y Salud Pública
Gress, Thomas; Philipps-University of Marburg, Department of 
Gastroenterology




Crnogorac-Jurcevic, Tatjana; Barts Cancer Institute, Queen Mary 
University of London, Centre for Molecular Oncology
Muñoz-Bellvis, Luis; Hospital Universitario de Salamanca-IBSAL, 
Salamanca, Servicio de Cirugía General y Aparato digestivo
Domínguez-Muñoz, Enrique; Hospital Clinico Universitario de Santiago de 
Compostela, Department of Gastroenterology
Balsells, Joaquim; Hospital Vall d'Hebron, Exocrine Pancreas Research 
Unit and Vall d'Hebron Research Institute (VHIR); Universitat Autonoma 
de Barcelona, Campus de la UAB; Centro de Investigación Biomédica en 
Red, Enfermedades Hepáticas y Digestivas
Costello, Eithne; Royal Liverpool University Hospital,  Department of 
Molecular and Clinical Cancer Medicine
Iglesias, Mar; Hospital del Mar, Pathology Department
Kleeff, Jörg; Tecnnical University of Munich, Surgery; Martin-Luther-
Universitat Halle-Wittenberg, Visceral, Vascular and Endocrine Surgery
Kong, Bo; Technical University of Munich, Department of Surgery; 
Technical University of Munich, Department of Surgery
Mora, Josefina; Hospital de la Santa Creu i Sant Pau,  Department of 
Gastroenterology
O’Driscoll, Damian; University College Cork National University of 
Ireland, HRB Clinical Research Facility ; University College Cork National 
University of Ireland, Clinical Research Facility
Povés, Ignacio; Hospital del Mar, Surgery
Scarpa, Aldo; University of Verona, ARC-NET Center fo rApplied Research 
on Cancer
Yu, Jingru; Karolinska Institute, Department of Medical Epidemiology and 
Biostatistics
Ye, Weimin; Karolinska Institute, Department of Medical Epidemiology 
and Biostatistics
Hidalgo, Manuel; Dana Farber Cancer Institute, Harvard Medical School
Carrato, Alfredo; Hospital Ramon y Cajal, Oncology
Lawlor, Rita; University and Hospital trust of Verona, ARC-Net centre for 
Applied Research on Cancer and Department of Pathology and 
Diagnostics;  Pathology and Public Health
Real, Francisco; Spanish National Cancer Research Centre, Epithelial 
Carcinogenesis; Spanish ational Cancer Research Center, Genetic and 
Molecular Epidemioloy Unit
Malats, Nuria; Spanish National Cancer Research Centre, Genetic and 
Molecular Epidemiology
Keywords: Pancreatic cancer risk, Smoking habit, Type of tobacco, Dose-response relationship, Case-control study
Abstract:
BACKGROUND: Despite smoking being a well-established risk factor for 
pancreatic cancer (PC), there is a need to further characterize the PC risk 
according to lifespan smoking patterns and other smoking features such 
as tobacco type. Our aim was to deeply investigate them within a large 
European case-control study. 
PATIENTS AND METHODS: Tobacco smoking habits and other relevant 
information was obtained from 2,009 cases and 1,532 controls recruited 
in the PanGenEU study using standardized tools. Multivariate logistic 
regression analysis was performed to evaluate PC risk by smoking 
characteristics and interactions with other PC risk factors. Fractional 
polynomials and restricted cubic splines were used to test for non-
linearity of the dose-response relationships and to analyse their shape. 
RESULTS: Relative to never-smokers, current smokers (OR=1.72, 
95%CI: 1.39-2.12), those inhaling into the throat (OR=1.48, 95%CI: 
1.11-1.99), chest (OR=1.33, 95%CI: 1.12-1.58), or using non-filtered 
cigarettes (OR=1.69, 95%CI: 1.10-2.61), were all at an increased PC 
risk. PC risk was higher in current smokers of black tobacco (OR=2.08, 
95%CI: 1.29-3.36). Childhood exposure to tobacco smoke from parental 






























































smoking was also associated with increased PC risk (OR=1.24, 95%CI: 
1.03-1.49). Dose-response relationships for smoking duration, intensity, 
cumulative dose, and smoking cessation were non-linear and showed 
different shapes by tobacco type. Effect modification were observed for 
family history of PC and diabetes status (p-value for interaction<0.001). 
CONCLUSIONS: This study reveals differences in PC risk by tobacco type 
and other habit characteristics, as well as non-linear risk associations, 
emphasizing potential differences in the underlying mechanisms leading 
to PC.
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Abstract
BACKGROUND: Despite smoking being a well-established risk factor for pancreatic cancer (PC), there 
is a need to further characterize the PC risk according to lifespan smoking patterns and other smoking 
features such as tobacco type. Our aim was to deeply investigate them within a large European case-
control study.
PATIENTS AND METHODS: Tobacco smoking habits and other relevant information was obtained from 
2,009 cases and 1,532 controls recruited in the PanGenEU study using standardized tools. Multivariate 
logistic regression analysis was performed to evaluate PC risk by smoking characteristics and 
interactions with other PC risk factors. Fractional polynomials and restricted cubic splines were used to 
test for non-linearity of the dose-response relationships and to analyse their shape. 
RESULTS: Relative to never-smokers, current smokers (OR=1.72, 95%CI: 1.39-2.12), those inhaling into 
the throat (OR=1.48, 95%CI: 1.11-1.99), chest (OR=1.33, 95%CI: 1.12-1.58), or using non-filtered 
cigarettes (OR=1.69, 95%CI: 1.10-2.61), were all at an increased PC risk. PC risk was higher in current 
smokers of black tobacco (OR=2.08, 95%CI: 1.29-3.36). Childhood exposure to tobacco smoke from 
parental smoking was also associated with increased PC risk (OR=1.24, 95%CI: 1.03-1.49). Dose-
response relationships for smoking duration, intensity, cumulative dose, and smoking cessation were 
non-linear and showe d different shapes by tobacco type. Effect modification were observed for family 
history of PC and diabetes status (p-value for interaction<0.001).
CONCLUSIONS: This study reveals differences in PC risk by tobacco type and other habit 
characteristics, as well as non-linear risk associations, emphasizing potential differences in the 
underlying mechanisms leading to PC.
Key words: Pancreatic cancer risk; Smoking habit; Type of tobacco; Dose-response relationship; 
Fractional polynomials; Restricted cubic splines; Case-control study. 
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Key message:
 This study sheds light on still unknown tobacco-related associations with pancreatic cancer risk. 
Differences in pancreatic cancer risk by tobacco type, as well as the non-linear risk associations 
by timing of the exposure, points to a complex multi-mechanism process underlying pancreatic 
carcinogenesis among smokers.
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Introduction
Pancreatic cancer (PC) is one of the deadliest cancer types worldwide (5-year relative survival 
rate in the range 5-15%)[1], and within western countries[2]. It is estimated that 10-30% of all PC cases 
are caused by smoking[3]. However, a detailed characterization of tobacco smoking habits in relation to 
PC risk is still lacking. A meta-analysis including 10,490 cases and 526,813 controls, showed that being 
a current smoker, jointly with a longer smoking duration and a higher smoking intensity, was associated 
with an increase in PC risk[4]. However, the authors assumed a linear trend for PC risk associated with 
increasing smoking exposure, a fact disputed by Zou et al. in an updated analysis combining 9,044 cases 
and 32,039 controls showing a non-linear dose-response relationship (DRR) between several smoking 
features and PC risk[5]. A pooled analysis within the Pancreatic Cancer Case-Control Consortium 
(PanC4), including 6,507 cases and 12,890 controls, indicated that after a certain amount of smoking 
exposure PC risk levelled-off[6], shedding a different perspective on the DRR of smoking in relation to 
PC risk. In the aforementioned studies, an exploration of the shape of the association between smoking 
measures and PC risk was not further pursued. 
Moreover, several aspects of tobacco smoking habits have not been considered until now. For 
instance, differences in PC risk by either black or blond tobacco use have not been explored despite the 
presumed differences in their chemical composition and damaging effects[7, 8]. In fact, several studies 
have shown that black tobacco is associated with higher risk of bladder[7], colorectal[9], oesophageal[10], 
and head-and-neck cancer[11,12], than blond tobacco. 
Therefore, we set out to investigate the association and DRR between tobacco smoking and PC 
risk in a large European population, considering every aspect of the smoking habit including use of black 
versus blond tobacco. 
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Methods
Study design and participants
Details of the study population are provided in supplementary methods and elsewhere[13, 14].
Variables
Personal interviews were conducted by trained monitors using standardized protocols and 
questionnaires to obtain detailed information on lifetime smoking habits, among other PC risk factors. 
Information on smoking habits by tobacco type (only black, blond or both) was only collected in the 
Spanish centres. Further information is available in supplementary methods.  
Statistical analysis
Unconditional logistic regression analysis was performed to estimate odds ratios (OR) and 95% 
Confidence Intervals (95%CI). A comprehensive description of the model specifications is given in 
supplementary methods. The influence of confounding factors or effect modification on the association 
was assessed for several variables. Variables changing estimates by more than 10% or having a 
significant influence in the model (diabetes and family history of PC in some smoking-related variables) 
were considered as potential confounders. The le Cessie-van Houwelingen-Copas-Hosmer unweighted 
sum of squares test indicated a high goodness of fit of the models[15]. Effect modification was assessed 
in interaction and stratified analyses. Additive interaction by time-related variables such as smoking 
duration was also evaluated by the relative excess risk due to interaction (RERI) and Delta-method 
CIs[16]. Imputation of missing values was performed using the Random Forest algorithm (R package 
missForest) (Supplementary methods and Supplementary Table 1). More information is provided in 
supplementary methods.
To assess the DRRs, PC risk estimates were calculated per 1-unit of increase in continuous 
smoking exposure variables considering linear and non-linear models if so indicated by fractional 
polynomials (FP) (R package mfp)[17]. In addition, restricted cubic splines (RCS) were used to confirm 
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non-linear associations and for modelling the shape of the DRRs (R package splines)[18]. Non-linearity 
of the models was tested via the likelihood-ratio test comparing the model with and without RCS. Knots 
were set at the 10%, 50% and 90% percentile of the exposure distribution;comparable results were 
obtained with five knots[19]. Sensitivity analyses are described in supplementary methods. Specific 
analyses were devoted to RCS, which performance was assessed  by additional smoothing, allowing 
more flexibility into the model[20]. 
The threshold for statistical significance in two-sided tests was set at p-value<0.05. Data was 
analysed with R-project (version 3.4.1)[21]. 
Results
PC cases (N=2,009) presented more frequently with a family history of PC and a diagnosis of 
diabetes or chronic pancreatitis than controls (N=1,532) (Supplementary Table 2).
The prevalence of smoking was higher in cases (27.4%) than in controls (17.6%), with a 
corresponding aOR of 1.72 (95%CI: 1.39-2.12) for current smokers compared to never-smokers (Table 
1 and Supplementary Table 3). Furthermore, a statistically significant increased trend (p-value<0.001) in 
PC risk was observed for longer smoking duration, higher smoking intensity and higher cumulative dose. 
The use of non-filtered cigarettes increased risk of PC more prominently (aOR=1.69, 95%CI: 1.10-2.61), 
although use of filtered cigarettes was also associated with an increased PC risk (aOR=1.25, 95%CI: 
1.06-1.48). Marked increases in PC risk were also observed for inhalation into the throat (aOR=1.48, 
95%CI: 1.11-1.99) and chest (aOR=1.33, 95%CI: 1.12-1.58). Childhood exposure to ETS by smoking 
parents (vs. non-parental exposure) was associated with a 24% (95%CI: 1.03-1.49) increased PC risk. 
Risk for former smokers decreased progressively with longer time since smoking cessation when 
compared to current smokers (aOR for 14-28 years after cessation=0.67, 95%CI: 0.51-0.88). No 
significant associations between PC risk and other smoking variables were observed (Supplementary 






























































PanGenEU: Smoking & PC risk (02 05 2019) 9
Table 4). Additional adjustment for diabetes and family history of PC led to minimal differences in risk 
estimates (Supplementary Table 4). Effect modification was apparent only for family history of PC and 
diabetes status (Supplementary Table 5), pointing towards a higher PC risk among current smokers with 
family history of the disease (aOR=2.24, 95%CI: 0.66-7.61) and former smokers with diabetes 
(aOR=1.44, 95%CI: 0.91-2.28) (p-value for interaction<0.001).
Table 1 also shows PC risk estimates by tobacco type in PanGenEU-Spain. Compared to never-
smokers, PC risk was significantly increased for smokers of only black tobacco (aOR=1.55, 95%CI: 1.13-
2.12) and of both tobacco types (aOR=1.58, 95%CI: 1.14-2.17). Among blond tobacco smokers, PC risk 
tended to be increased (aOR=1.23, 95%CI: 0.94-1.62), though without reaching statistical significance. 
By smoking status, a significant increase in risk was observed for current smokers of only black tobacco 
(aOR=2.08, 95%CI 1.29 - 3.36). In combined effect analyses (Supplementary Table 6), smoking for ≥30 
years of both tobacco types was associated with a higher PC risk than smoking only black or blond 
tobacco (aOR=2.05, 95%CI: 1.25-3.36).
Adjusted FP models suggested non-linear associations and a statistically significantly higher PC 
risk per 1-unit increase in smoking duration, smoking intensity and cumulative dose, and decreasing PC 
risks for age at smoking initiation and time since smoking cessation (Supplementary Table 7). The RCS 
confirmed these non-linear associations. Compared to never-smokers, smoking for >25 years (Figure 1, 
A-B) and smoking >20 cigarettes/day (Figure 1, D-E) was associated with a statistically significant 
increase of PC risk. Similarly, a cumulative dose of >14 pack-years was associated with increased PC 
risk (Figure 1, C). Visual inspection for smoking intensity and cumulative dose was suggestive of 
plateauing of PC risk, at approximately 27 cigarettes/day or pack-years. Concerning time since smoking 
cessation (Figure 1, F-I), and relative to current smokers, risk appeared to decrease between 8 and 11 
years of cessation and after around 18 years of cessation regardless of cumulative dose. In between 
these periods, the significant effect disappeared. By tobacco type, corresponding periods of significant 
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decrease in PC risk were observed for black tobacco (after about 14 years since cessation) and for blond 
tobacco (between 2 and 8 years and after >20 years of cessation). 
No relevant differences in the trend or magnitude of the estimates were found in sensitivity 
analyses (Supplementary Tables 8, 9, 10, and Supplementary Figure 1). In analyses adjusting for 
smoking intensity, risk estimates decreased in magnitude but showed a similar trend, even in black 
tobacco smokers despite being heavier smokers.(Supplementary Table 11). Importantly, adjustment for 
smoking duration led to non-significant risk estimates and change in the shape of the DRRs 
(Supplementary Table 12). Considering long-lasting smoking together with intense smoking increased 
PC risk, whereas for less intense smoking the association weakened (Supplementary Table 13).
Discussion
The present study confirms that, in comparison to never-smokers, being a current smoker 
increases the risk of PC by 72%. In terms of attributable risk, around 16% (95%CI: 9.24-22.47) of all PC 
diagnoses could be avoided through tobacco preventive measures. A more detailed examination of 
smoking characteristics showed that the use of non-filtered cigarettes, deep inhalation into the throat or 
chest, and exposure to tobacco smoke in the parental household were all associated with increased PC 
risk. PC risk in black tobacco smokers was significantly higher compared to never-smokers, with blond 
tobacco smokers showing a less prominent risk pattern. Analysis of DRRs corraborated that a higher 
smoking intensity, longer smoking duration, and increased levels of cumulative dose were associated 
with an increased PC risk, whereas smoking cessation led to a gradual decline in PC risk, all in a non-
linear manner.
Our results are concordant with earlier studies. Regarding the magnitude of PC risk associated 
with current versus never tobacco smoking, a meta-analysis and the PanC4 study showed similar 
estimates (RR=1.74, 95%CI: 1.61-1.87 and OR=2.20, 95%CI: 1.71-2.83, respectively)[4, 6]. Similarly, 
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our study confirmed the trends and timing of tobacco smoking[4, 6], the excess risk conferred by tobacco 
smoking[4], the non-linear tobacco-PC associations[5], and risk due to childhood ETS[22]. Compared 
with studies restricting ETS exposure to never-smokers, we also did not observe significant risk estimates 
(OR=1.24, 95%CI: 0.95-1.63)[23, 24]. In contrast to the positive association between current cigar/pipe 
smokers and PC risk reported before[4, 25], we did not observe a significant associations, probably due 
to low statistical power.
Effect-modification factors
Former smoking diabetes patients tended to have a higher PC risk in this study. Lifestyle changes 
including smoking cessation among diabetics may explain this finding together with the fact that smoking 
and its cessation is associated with insulin resistance[26]. Indeed, this result is consistent with the 
findings of a study reporting that smoking cessation leading to weight gain increases diabetes risk[27]. 
Previous studies suggested differences in smoking effects on PC risk by gender[5, 6], although they failed 
to demonstrate effect modification by this variable. Similarly, non-significant differences by gender were 
found in our study.
Dose-response relationships
Non-linear relationships of the association between smoking variables and PC risk were 
supported by both FP and RCS approaches. For smoking duration, intensity, and cumulative dose, a 
plateuing in the DRR was apparent. This observed pattern was previously reported[5], and could be 
attributed to the saturation of the detoxification processes of tobacco carcinogens in the body[28], or to 
a presumably weaker inhalation of tobacco smoke but stronger DNA repair efficiency among heavy 
smokers[29,30], amongst other factors. Non-linear associations for smoking cessation were also 
suggested in previous studies[5]. 
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Black versus blond tobacco-use 
Compared to never-smokers, black tobacco smokers showed a significantly higher PC risk. This 
potential harmful effect has also been observed in other cancers[7,9–12,31,32]. Smoking both black and 
blond tobacco for a long time (≥30 years) tended to be related to higher PC risk, this also being shown 
in previous studies[7]. 
The difference between the two tobacco types could be explained by their smoke composition: 
black tobacco mostly contains early-stage carcinogens, such as N-nitrosamines and aromatic amines 
including 4-amino-biphenyl and 2-naphthylamine[33], whereas blond tobacco may mostly consist of late-
stage carcinogens[31]. It is conceivable that black tobacco may predominantly cause DNA mutations 
whereas blond tobacco may preferentially act through epigenetic change, as has been shown for LINE-
1[8]. As a consequence, an immediate and significantly higher increase in PC risk could be expected in 
black tobacco smokers, while blond tobacco might need a longer time to trigger PC development. This 
may also imply that following smoking cessation of blond tobacco PC risk can keep increasing for some 
time, slowing down after recovery of certain DNA methylation changes. In fact, methylation changes due 
to smoking seem to persist up to 22 years after smoking cessation[34]. For black tobacco, instead, the 
PC risk reduction effects might not take place or might require longer since smoking cessation. Our 
results support these hypotheses to some extent. Compared to never-smokers, not only did black 
tobacco smoking have a more detrimental effect on PC risk, but also the risk tended to increase soon 
after smoking initiation, whereas downward risks were observed after smoking cessation for >10 years. 
A similar decreasing risk with long-term smoking cessation of black tobacco has been observed in bladder 
cancer [31,32]. Among blond tobacco smokers, the trend towards a reduction in PC risk became evident 
shortly after smoking cessation (Figure1). Thus, our study suggests that black tobacco consumption may 
play a role in several steps of the carcinogenic process with possibly both early and late-stage 
carcinogens being involved. For blond tobacco, our results point to a two-tier mechanism after smoking 
cessation driven by late-stage carcinogens, the first consisting of a sudden change in risk estimates with 






























































PanGenEU: Smoking & PC risk (02 05 2019) 13
risk levels more akin to never-smokers likely due to desaturation of detoxification routes of tobacco-
carcinogens[5,35], the second showing risks levelling-off once alteration of DNA methylation levels of key 
genes regain the state of normalcy.
Among the limitations of the study, stratifying by tobacco type and other variables might have 
underpowered the analyses to detect any differences. Also, we could not consider potential differences 
in the content of carcinogens because we lacked information on tobacco brands, likely to contain varying 
amounts of heavy metals[36] and other carcinogens[33]. Residual confounding can be therefore 
expected, also due to lack of, or imprecise, information on other relevant data such as ETS in adulthood. 
Moreover, differential misclassification of the exposure due to recall bias of smoking habits is possible..  
Strengths of the study are the large number of PC cases representing a European-wide PC 
population and the degree of detail in the information collected about smoking habits even considering 
tobacco types. Also, as a novelty, the shapes of DRRs have been fully characterized using different 
modelling strategies to account for non-linear effects of smoking on PC risk. 
In conclusion, findings of this study support and add to the previous evidence that smoking 
increases PC risk and demonstrates, for the first time, that both blond and black tobacco smoke are key 
in PC aetiology, though probably acting through different genetic mechanisms. 
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Tables and figures
Table 1: Association between smoking variables and pancreatic cancer risk in the PanGenEU study 
population (2,009 cases and 1,532 controls). 
Figure 1 (A-I): Dose-response relationships between several smoking variables and the risk of PC, 
depicted by restricted cubic splines with knots at 10%, 50% and 90%, represented as dashed, vertical 
lines. Adjusted for age, gender and country (for the PanGenEU study population), or region (for the 
PanGenEU-Spain study population). Restricted cubic splines are shown for the unimputed smoking 
variables, and additional adjustment variables were modelled as fractional polynomials to account for 
non-linear effects. The spline curve is shown as a black trend line and 95% confidence intervals are 
shadowed in grey. The dotted horizontal black line represents the reference odds ratio of 1. A: Smoking 
duration in years (PanGenEU); B: Smoking duration in years (PanGenEU), adjusted for smoking intensity 
(cigarettes per day); C: Cumulative dose in pack-years (PanGenEU); D: Smoking intensity in cigarettes 
per day (PanGenEU); E: Smoking intensity in cigarettes per day (PanGenEU), adjusted for smoking 
duration (years); F: Time since cessation in years (PanGenEU), adjusted for cumulative dose (pack-
years); G: Time since cessation in years (PanGenEU-Spain), adjusted for cumulative dose (pack-years); 
I: Time since cessation in years for smokers of only black tobacco (PanGenEU-Spain), adjusted for 
cumulative dose (pack-years); J: Time since cessation in years for smokers of only blond tobacco 
(PanGenEU-Spain), adjusted for cumulative dose (pack-years). PC: pancreatic cancer; RCS: restricted 
cubic splines.
Table 1: Association between smoking variables and pancreatic cancer risk in the PanGenEU study population (2,009 
cases and 1,532 controls).
Cases (%) Controls (%) p-value1 OR (95%CI) aOR (95%CI)
Smoking status (cigarettes) <0.001 p-trend <0.001 
 Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
 Occasional 33 (1.6) 42 (2.7) 0.72 (0.44 - 1.14) 1.00 (0.61 - 1.67)
 Former 667 (33.2) 530 (34.6) 1.14 (0.98 - 1.33) 1.14 (0.95 - 1.37)
 Current 550 (27.4) 270 (17.6) 1.85 (1.55 - 2.21) 1.72 (1.39 - 2.12)
Cumulative dose in tertiles (pack-years) <0.001 p-trend <0.001
 Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
 < 14 279 (13.9) 281 (18.3) 0.90 (0.74 - 1.10) 0.90 (0.72 - 1.13)
14 - 32 494 (24.6) 275 (18.0) 1.63 (1.36 - 1.96) 1.57 (1.27 - 1.94)
 ≥ 32 477 (23.7) 286 (18.7) 1.52 (1.27 - 1.81) 1.50 (1.21 - 1.84)
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Inhalation <0.001 p-trend <0.001
Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
Mouth only 125 (6.2) 99 (6.5) 1.15 (0.86 - 1.53) 1.10 (0.80 - 1.50)
Throat 158 (7.9) 108 (7.1) 1.33 (1.02 - 1.74) 1.48 (1.11 - 1.99)
Chest 967 (48.1) 635 (41.4) 1.38 (1.20 - 1.60) 1.33 (1.12 - 1.58)
Filter-use <0.001 p-trend <0.001
 Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
Filtered only 1042 (51.9) 706 (46.1) 1.34 (1.17 - 1.54) 1.25 (1.06 - 1.48)
Non-filtered only 65 (3.2) 49 (3.2) 1.20 (0.82 - 1.78) 1.69 (1.10 - 2.61)
 Both 143 (7.1) 87 (5.7) 1.49 (1.12 - 1.99) 1.65 (1.21 - 2.27)
ETS exposure during childhood <0.001 p-trend = 0.610
Both parents were never-smokers 420 (20.9) 391 (25.6) 1.00 1.00
One of the parents smoked 1378 (68.6) 952 (62.1) 1.35 (1.15 - 1.58) 1.24 (1.03 - 1.49)
Both parents smoked 211 (10.5) 189 (12.3) 1.04 (0.82 - 1.32) 1.07 (0.81 - 1.42)
Time since cessation in tertiles (years) <0.001 p-trend <0.001
Current smoker 551 (27.4) 274 (17.9) 1.00 1.00
< 14 320 (15.9) 191 (12.5) 0.83 (0.66 - 1.05) 0.81 (0.62 - 1.04)
14 - 28 229 (11.4) 185 (12.1) 0.62 (0.48 - 0.78) 0.67 (0.51 - 0.88)
≥ 28 150 (7.5) 192 (12.5) 0.39 (0.30 - 0.50) 0.49 (0.36 - 0.66)
Never-smoker 759 (37.8) 690 (45.0) - - - -
By tobacco type in PanGen-Spain2
Tobacco type 0.012  
Never-smoker 355 (40.5) 360 (47.2) 1.00 1.00
Smoker of black tobacco only 165 (18.8) 114 (15.0) 1.47 (1.11 - 1.94) 1.55 (1.13 - 2.12)
Smoker of blond tobacco only 204 (23.3) 182 (23.9) 1.14 (0.89 - 1.46) 1.23 (0.94 - 1.62)
Smoker of both tobacco types 152 (17.4) 106 (13.9) 1.45 (1.09 - 1.94) 1.58 (1.14 - 2.17)
Tobacco type by smoking status 0.028
Never-smoker 355 (40.5) 360 (47. 2) 1.00 1.00
Occasional
   Black tobacco 1 (0.1) 4 (0.5) 0.28 (0.01 - 2.03) 0.29 (0.03 - 2.64)
   Blond tobacco 11 (1.2) 11 (1.4) 1.01 (0.42 - 2.42) 1.11 (0.47 - 2.62)
   Both 2 (0.2) 2 (0.4) 1.01 (0.11 - 9.78) 1.16 (0.16 - 8.39)
Former
   Black tobacco 104 (11.9) 79 (10.4) 1.33 (0.96 - 1.85) 1.39 (0.97 - 1.98)
   Blond tobacco 90 (10.3) 88 (11.5) 1.04 (0.75 - 1.44) 1.11 (0.79 - 1.56)
   Both 76 (8.7) 58 (7.6) 1.33 (0.92 - 1.93) 1.43 (0.96 - 2.12)
Current
   Black tobacco 60 (6.8) 31 (4.1) 1.96 (1.25 - 3.13) 2.08 (1.29 - 3.36)
   Blond tobacco 103 (11.8) 83 (10.9) 1.26 (0.91 - 1.74) 1.43 (1.00 - 2.03)
   Both 74 (8.5) 46 (6.0) 1.63 (1.10 - 2.44) 1.80 (1.18 - 2.74)
ETS: environmental tobacco smoke. Risk estimates are shown for the imputed smoking variables. aOR: adjusted OR. Adjusted model for age (≤ 54, 55-64, 65-74, ≥75 years), 
gender (male, female) and country (Spain, England, Germany, Ireland, Italy, Sweden). Random effects model applied for country. 1 Chi-square test applied to evaluate differences 
between the groups. Significance was set at p-value<0.05. 2  PanGenEU-Spain study population (876 cases and 762 controls). Adjusted model for age (≤ 54, 55-64, 65-74, ≥75 
years), gender (male, female) and region (East, Central and Northern Spain).
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Supplementary methods
Study design and participants
The PanGenEU (European Study on Digestive Illnesses and Genetics) is an ongoing multicentre 
case-control study recruiting participants from Germany, Ireland, Italy, Spain, Sweden and United 
Kingdom. Newly diagnosed pancreatic cancer (PC) patients >18 years old and controls matched by age, 
gender, and geographical area were included. A rapid ascertainment approach was applied: patients with 
a suspicion of PC were recruited and remained in the study if the diagnosis was verified by the treating 
physician. Controls were mostly hospital-based and eligible if principal diagnosis at admission was 
unrelated to known risk factors of PC. Population-based controls (Sweden and Ireland) were eligible if 
history of PC was absent. Participation rates were 86.3% for cases and 77.8% for controls. The study 
was approved by the IRB of all participant centres and all subjects gave written informed consent.
Variables
The smoking status of the participants was categorized into never, former and current smokers 
based upon the information they provided. In particular, the smoking status of the participants was 
categorized into never-smokers if they smoked <100 cigarettes during their lifetime; occasional smokers 
if they smoked ≥1 cigarette/day for ≥6 months; former smokers if they quitted smoking for >1 year; and 
current smokers otherwise (>100 cigarettes during lifetime without permanent smoking cessation). 
Smoking exposure was further assessed by the age at smoking initiation (years), age when last smoked 
(years), cigarettes/cigar/pipe-use (yes, no), the amount of cigarettes/cigars/pipes smoked in units of time 
(days, months, years), depth of inhalation (mouth, throat, chest), filter-use (filtered cigarettes, non-filtered, 
both), and smoking status of the parents (never- or ever-smoker). From these characteristics, data on 
smoking duration (years), smoking intensity for cigarettes (per day) and cigars/pipes (per week), and time 
since cessation (years) was derived. Number of pack-years, representing cumulative dose, was 






























































PanGenEU: Smoking & PC risk – Supplementary Material (02 05 2019) 3
calculated as (cigarettes per day/20)*smoking duration in years. Smoking variables by use of tobacco 
type were generated likewise. Environmental tobacco smoke (ETS) exposure during childhood was 
categorized according to the smoking status of the parents (none, one, or both). 
Statistical analysis
Differences between cases and controls regarding smoking characteristics were evaluated by χ2 
and Student’s t-test (or Kruskal–Wallis test, where appropriate). Unconditional logistic regression analysis 
was performed to estimate odds ratios (OR) and 95% Confidence Intervals (95%CI). Never-smokers 
were chosen as the reference category, except for the variables “age when last smoked” and “time since 
smoking cessation”, where current smokers were taken as the reference. Tertiles were created for the 
continuous variables based on the distribution of controls. A p-value for trend was calculated by assuming 
ordinal variables in linear regression mod ls. Age (≤54, 55-64, 65-74, ≥75 years), gender, and country-
adjusted models (aOR) were considered. For the tobacco type-specific analyses within the Spanish 
PanGenEU study population, the same model was applied, but replacing country by region (East, Central 
and Northern Spain). The attributable risk (AR) of smoking in relation to PC was calculated by applying 
the same models. Since heterogeneity by country (p<0.05) was evident for all smoking variables, random 
effects for country were applied in mixed effects models. Due to absence of heterogeneity in the Spanish 
study population, logistic regression models without random effects were considered. 
The influence of other factors on the association between tobacco smoking and PC risk was 
assessed for gender (female, male), age (<65 years, ≥ 65 years), obesity (body mass index >30: yes, 
no), diabetes (no, yes less than 2 years, yes more than 2 years), asthma (yes, no), chronic pancreatitis 
(yes, no), alcohol status/consumption (never, former, current), presence of periodontitis (yes, no) and 
recession (yes, no), educational level as a proxy for socioeconomic status (low, medium, high), and family 
history of PC (yes, no). 
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To test for interaction, a likelihood ratio (LR) test was performed comparing models with and 
without an interaction term between the smoking variables and the covariates (e.g., age, gender, BMI 
and obesity, diabetes, asthma, alcohol, periodontitis, recession, educational level, and family history of 
PC). Effect modification was tested further via stratified analyses. To assess interaction by time-related 
variables we explored the combined effect of smoking duration and other smoking characteristics such 
as tobacco type on PC risk. Smoking duration was categorized into <20, 20-30, and ≥30 years of smoking 
and stratified further by tobacco type considering never-smokers as the reference category.
Imputation
Missing values were assumed to be at random. Predictor variables such as centre, country, and 
case-control status were kept in the imputation set. The performance of the imputation was assessed by 
calculating the out of bag mean square error (OOB), representing the mean of squared differences 
between each observed value and its prediction, based on random forest trees (n=100 was applied). The 
average OOB for all smoking variables was 5.27, with categorical variables presenting a markedly lower 
estimate (OOB=0.04), indicating a better imputation performance of the latter (Supplementary Table 1). 
Use of unimputed data of all continuous variables, for which the proportion of missing values was 
relatively low (6.7%), was therefore deemed more appropriate for dose-response analyses. The 
performance of the imputation was also assessed with concordance rates between the observed and 
imputed data, considering a test dataset consisting of only subjects with complete data and missing 
values introduced by following the missingness rates of the original data. The concordance of all 
categorical variables was 94.4% (Supplementary Table 1). 
Sensitivity analyses
Sensitivity analyses were performed comparing the risk estimates in magnitude and trend 
regarding the unimputed and imputed data, and the PanGenEU study population with and without Italy 
(since Italy provided cases only). As information bias could be induced by neglecting the quantity of 
smoking exposure, adjustment for cumulative dose (pack-years) was considered, thereby accounting for 
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both smoking duration and smoking intensity. Additional adjustments were made also for smoking 
intensity and duration separately, to assess both the individual and joined effects of smoking 
characteristics independent of smoking duration and/or intensity. These adjustment variables were 
considered on the continuous scale and modelled as FPs to account for non-linear effects. 
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Supplementary Table 1. Imputation performance on the PanGenEU study population (2,009 cases and 1,532 controls), 




































































































Country 0 0.00 0.00 0 0 0 NA 0.00
Center 0 0.00 0.00 0 0 0 NA 0.00
Region 0 0.00 0.00 0 0 0 NA 0.00
Study 0 0.00 0.00 0 0 0 NA 0.00
Case-control status 0 0.00 0.00 0 0 0 NA 0.00
Age 12 0.34 0.43 0 2 2 0.00 0.41
Gender 4 0.11 0.13 4 0 4 100.00 0.12
Years of education (continuous) 751 21.21 9.58 0 152 152 0.00 7.21
Educational level 1252 35.36 0.50 111 109 220 50.46 0.33
Socioeconomic status 180 5.08 0.06 49 4 53 92.45 0.02
Height (continuous) 76 2.15 19.35 0 11 11 0.00 0.00
Height in tertiles 76 2.15 0.03 13 1 14 92.86 0.01
Weight (continuous) 120 3.39 31.39 0 30 30 0.00 81.53
Weight in tertiles 120 3.39 0.01 36 0 36 100.00 0.01
BMI 170 4.80 0.11 25 6 31 80.65 0.09
Smoking variables         
Ever smoked 100 cigarettes 12 0.34 0.00 2 0 2 100.00 0.00
Regular smoker 87 2.46 0.01 24 0 24 100.00 0.00
Tobacco type3 1185 33.47 0.22 161 43 204 78.92 0.14
Age at smoking initiation (continuous) 75 2.12 5.93 1 16 17 5.88 7.89
Age at smoking initiation in tertiles 75 2.12 0.02 20 1 21 95.24 0.00
Current smoker 69 1.95 0.02 20 0 20 100.00 0.01
Age last smoked (continuous) 97 2.74 18.20 3 17 20 15.00 13.77
Age last smoked in tertiles 98 2.77 0.02 17 1 18 94.44 0.01
Ever quit smoking >6 months 223 6.30 0.00 49 0 49 100.00 0.00
Time of ever quitting (continuous) 266 7.51 2.93 17 37 54 31.48 5.42
Time of ever quitting in tertiles 266 7.51 0.04 59 2 61 96.72 0.00
Inhalation 341 9.63 0.16 60 12 72 83.33 0.15
Filter-use 393 11.10 0.10 67 10 77 87.01 0.11
Smoking cigar 437 12.34 0.01 97 0 97 100.00 0.00
Intensity of smoking cigars (continuous) 556 15.70 0.87 38 83 121 31.41 12.73
Intensity of smoking cigars in tertiles 558 15.76 0.03 133 4 137 97.08 0.01
Smoking pipe 439 12.40 0.00 91 0 91 100.00 0.00
Intensity of smoking pipes (continuous) 586 16.55 0.28 84 38 122 68.85 10.99
Intensity of smoking pipes in tertiles 586 16.55 0.02 121 1 122 99.18 0.01
Tobacco type for pipe 631 17.82 0.01 112 2 114 98.25 0.03
Smoking status (cigarettes) 113 3.19 0.00 23 0 23 100.00 0.00
Smoking status (incl. occasional) 85 2.40 0.01 29 0 29 100.00 0.00
Smoking duration (continuous) 332 9.38 25.03 3 61 64 4.69 10.22
Smoking duration in tertiles 333 9.40 0.01 64 3 67 95.52 0.00
Smoking intensity (continuous) 110 3.11 13.45 1 27 28 3.57 23.37
Smoking intensity in tertiles 110 3.11 0.02 20 0 20 100.00 0.00
Cumulative dose (continuous) 356 10.05 177.11 16 52 68 23.53 82.15
Cumulative dose in tertiles 356 10.05 0.01 81 1 82 98.78 0.00
Time since cessation (continuous) 145 4.10 6.24 7 25 32 21.88 6.31
Time since cessation in tertiles 145 4.10 0.01 28 1 29 96.55 0.00
Quit smoking <10 or ≥ 10 years ago 144 4.07 0.00 25 0 25 100.00 0.00
Childhood exposure to ETS 537 15.17 0.02 123 5 128 96.09 0.01
Combined use of cigarettes, cigars, pipes 444 12.54 0.49 48 49 97 49.49 0.47
Medical history         
Ever been diagnosed with asthma 329 9.29 0.09 60 5 65 92.31 0.09
Ever been diagnosed with diabetes 54 1.53 0.00 11 0 11 100.00 0.00
Ever been diagnosed with diabetes (incl. time) 92 2.60 0.10 18 2 20 90.00 0.07
Ever been diagnosed with chronic pancreatitis 128 3.62 0.01 35 0 35 100.00 0.01
Ever been diagnosed with acid regurgitation 334 9.43 0.26 64 19 83 77.11 0.23
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Alcohol status 32 0.90 0.00 6 1 7 85.71 0.00
Alcohol intake (continuous) 798 22.54 4078.85 1 164 165 0.61 13.51
Alcohol intake in categories 802 22.65 0.05 146 12 158 92.41 0.02
Ever been diagnosed with obesity 176 4.97 0.00 45 0 45 100.00 0.00
Ever been diagnosed with periodontitis 936 26.43 0.19 148 28 176 84.09 0.18
Ever been diagnosed with recession 1319 37.25 0.33 155 62 217 71.43 0.28
Smoking status mother 364 10.28 0.03 74 2 76 97.37 0.00
Smoking status father 498 14.06 0.02 105 3 108 97.22 0.00
Family history of PC 124 3.50 0.05 26 1 27 96.30 0.05
OOB: out of bag; BMI: body mass index; ETS: environmental tobacco smoke; PC: pancreatic cancer.
1 Total proportion of missings in the PanGenEU study population, for adjustment and stratification variables was 8.5% (9.7% for cases, 
  6.9% for controls); Total proportion of missings in the PanGenEU-Spain study population, for adjustment and stratification variables  
  was 4.7% (4.8% for cases, 4.5% for controls).
2 The test set contains only subjects without missing (N=841).
3 Tobacco type was only collected for Spanish subjects.
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Supplementary Table 2: Baseline characteristics of the PanGenEU study population (2,009 cases and 1,532 controls).
PanGenEU PanGenEU - Spain
 Cases (%) Controls (%) p-value2 Cases (%) Controls (%) p-value2
Country <0.001 --
 Spain 876 (43.6) 762 (49.7) 876 (100.0) 762 (100.0)
 England 126 (6.3) 22 (1.4) - - - -
 Germany 130 (6.5) 111 (7.3) - - - -
 Ireland 173 (8.6) 290 (18.9) - - - -
 Italy 533 (26.5) 0 (0.0) - - - -
 Sweden 171 (8.5) 347 (22.7) - - - -
Gender 0.164 0.455
 Female 871 (43.4) 701 (45.8) 384 (43.8) 349 (45.8)
 Male 1138 (56.6) 831 (54.2) 492 (56.2) 413 (54.2)
Age <0.001 0.086
≤54 413 (20.6) 262 (17.1) 157 (17.9) 155 (20.3)
55-64 497 (24.7) 321 (21.0) 203 (23.2) 173 (22.7)
65-74 699 (34.8) 495 (32.3) 285 (32.5) 208 (27.3)
≥75 400 (19.9) 454 (29.6) 231 (26.4) 226 (29.7)
BMI (kg/m2) 0.997 0.900
 < 25 769 (38.3) 588 (38.4) 303 (34.6) 271 (35.6)
 25-29.99 854 (42.5) 651 (42.5) 397 (45.3) 343 (45.0)
 ≥ 30 386 (19.2) 293 (19.1) 176 (20.1) 148 (19.4)
Alcohol status3 <0.001 0.412
Never-drinker 585 (29.1) 383 (25.0) 273 (31.2) 254 (33.3)
Light drinker 805 (40.1) 756 (49.3) 377 (43.0) 338 (44.4)
Moderate drinker 564 (28.1) 360 (23.5) 214 (24.4) 160 (21.0)
Heavy drinker 55 (2.7) 33 (2.2) 12 (1.4) 10 (1.3)
Family history of PC <0.001 <0.001
No 1882 (93.7) 1492 (97.4) 815 (93.00) 739 (97.0)
Yes 127 (6.3) 40 (2.6) 61 (7.0) 23 (3.0)
Ever been diagnosed with asthma <0.001 0.014
No 1878 (93.5) 1374 (89.7) 817 (93.3) 684 (89.8)
Yes 131 (6.5) 158 (10.3) 59 (6.7) 78 (10.2)
Ever been diagnosed with diabetes <0.001 <0.001
 No 1515 (75.4) 1349 (88.1) 604 (68.9) 630 (82.7)
Yes, ≤ 2 years 214 (10.7) 27 (1.7) 112 (12.8) 20 (2.6)
 Yes, >2 years 280 (13.9) 156 (10.2) 160 (18.3) 112 (14.7)
Ever been diagnosed with chronic pancreatitis 0.004 0.460
No 1990 (99.1) 1530 (99.9) 871 (99.4) 760 (99.7)
Yes 19 (0.9) 2 (0.1) 5 (0.6) 2 (0.3)
PC: pancreatic cancer; BMI: body mass index.
Descriptives are shown for the imputed baseline characteristics. Descriptives of the unimputed baseline characteristics can be found in supplementary 
Table 8
1 Chi-square test applied to evaluate differences between the groups. Significance was set at p-value<0.05.
2 Light drinker: 0-1 drink/day for men and women; Moderate drinker: men: 1-5drinks/day, women: 1-2.5 drinks/day; Heavy drinker: men: ≥5drinks/day, 
women: ≥2.5 drinks/day.
Supplementary Table 3: Association between selected smoking variables and pancreatic cancer risk in the PanGenEU study 
population (2,009 cases and 1,532 controls).
 Unadjusted Adjusted
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ETS: environmental tobacco smoke.
Risk estimates are shown for the imputed smoking variables. Risk estimates of the unimputed smoking variables can be found in supplementary Table 4
Adjusted model for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and country (Spain, England, Germany, Ireland, Italy, Sweden). Random 
effects model applied for country.
1 Chi-square test applied to evaluate differences between the groups. Significance was set at p-value<0.05.
Cases (%) Controls (%) p-value1 OR (95%CI) aOR (95%CI)
Smoking status (cigarettes) <0.001  
 Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
 Occasional 33 (1.6) 42 (2.7) 0.72 (0.44 - 1.14) 1.00 (0.61 - 1.67)
 Former 667 (33.2) 530 (34.6) 1.14 (0.98 - 1.33) 1.14 (0.95 - 1.37)
 Current 550 (27.4) 270 (17.6) 1.85 (1.55 - 2.21) 1.72 (1.39 - 2.12)
p-trend <0.001
Smoking intensity in tertiles (cigarettes per day) <0.001
 Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
 < 10 389 (19.4) 343 (22.5) 1.03 (0.86 - 1.23) 1.02 (0.83 - 1.25)
10 - 20 533 (26.5) 287 (18.7) 1.69 (1.42 - 2.02) 1.64 (1.34 - 2.02)
≥ 20 328 (16.3) 212 (13.8) 1.41 (1.15 - 1.72) 1.41 (1.12 - 1.78)
p-trend <0.001
Smoking duration in tertiles (years) <0.001
Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
< 23 292 (14.5) 284 (18.5) 0.93 (0.77 - 1.13) 0.91 (0.72 - 1.14)
23 - 35 477 (23.8) 281 (18.4) 1.54 (1.29 - 1.85) 1.52 (1.23 - 1.87)
≥ 35 481 (23.9) 277 (18.1) 1.58 (1.32 - 1.89) 1.51 (1.23 - 1.86)
p-trend <0.001
Cumulative dose in tertiles (pack-years) <0.001
 Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
 < 14 279 (13.9) 281 (18.3) 0.90 (0.74 - 1.10) 0.90 (0.72 - 1.13)
14 - 32 494 (24.6) 275 (18.0) 1.63 (1.36 - 1.96) 1.57 (1.27 - 1.94)
 ≥ 32 477 (23.7) 286 (18.7) 1.52 (1.27 - 1.81) 1.50 (1.21 - 1.84)
p-trend <0.001
Age at smoking initiation in tertiles (years) <0.001
Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
< 15 423 (21.1) 278 (18.1) 1.38 (1.15 - 1.66) 1.36 (1.10 - 1.70)
15 - 18 455 (22.6) 299 (19.6) 1.38 (1.16 - 1.65) 1.31 (1.06 - 1.61)
≥ 18 372 (18.5) 265 (17.3) 1.28 (1.06 - 1.54) 1.29 (1.04 - 1.59)
p-trend = 0.010
Inhalation <0.001
Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
Mouth only 125 (6.2) 99 (6.5) 1.15 (0.86 - 1.53) 1.10 (0.80 - 1.50)
Throat 158 (7.9) 108 (7.1) 1.33 (1.02 - 1.74) 1.48 (1.11 - 1.99)
Chest 967 (48.1) 635 (41.4) 1.38 (1.20 - 1.60) 1.33 (1.12 - 1.58)
p-trend <0.001
Filter-use <0.001
 Never-smoker 759 (37.8) 690 (45.0) 1.00 1.00
Filtered only 1042 (51.9) 706 (46.1) 1.34 (1.17 - 1.54) 1.25 (1.06 - 1.48)
Non-filtered only 65 (3.2) 49 (3.2) 1.20 (0.82 - 1.78) 1.69 (1.10 - 2.61)
 Both 143 (7.1) 87 (5.7) 1.49 (1.12 - 1.99) 1.65 (1.21 - 2.27)
p-trend <0.001
ETS exposure during childhood <0.001
Both parents were never-smokers 420 (20.9) 391 (25.6) 1.00 1.00
One of the parents smoked 1378 (68.6) 952 (62.1) 1.35 (1.15 - 1.58) 1.24 (1.03 - 1.49)
Both parents smoked 211 (10.5) 189 (12.3) 1.04 (0.82 - 1.32) 1.07 (0.81 - 1.42)
p-trend = 0.610
Time since cessation in tertiles (years) <0.001
Current smoker 551 (27.4) 274 (17.9) 1.00 1.00
< 14 320 (15.9) 191 (12.5) 0.83 (0.66 - 1.05) 0.81 (0.62 - 1.04)
14 - 28 229 (11.4) 185 (12.1) 0.62 (0.48 - 0.78) 0.67 (0.51 - 0.88)
≥ 28 150 (7.5) 192 (12.5) 0.39 (0.30 - 0.50) 0.49 (0.36 - 0.66)
Never-smoker 759 (37.8) 690 (45.0) - - - -
p-trend <0.001
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Supplementary Table 4. Association between other smoking variables and pancreatic cancer risk in the PanGenEU study population (2,009 cases and 1,532 controls).
 Unadjusted Model 1 Model 2
Cases, % Controls, % p-value1 OR (95%CI) OR (95%CI) OR (95%CI)
Ever smoked 100 cigarettes <0.001   
No 764 38.00 691 45.10 1.00 1.00 1.00
 Yes 1245 62.00 841 54.90 1.34 (1.17 - 1.53) 1.30 (1.11 - 1.53) 1.28 (1.09 - 1.51)
Regular smoker <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Regular smoker 1217 60.60 800 52.20 1.38 (1.21 - 1.58) 1.33 (1.13 - 1.57) 1.31 (1.11 - 1.55)
 Occasional smoker 33 1.64 42 2.74 0.72 (0.44 - 1.14) 1.01 (0.61 - 1.68) 1.06 (0.63 - 1.77)
Tobacco type2 0.012
 Never-smoker 355 40.50 360 47.20 1.00 1.00 1.00
 Smoker of black tobacco only 165 18.80 114 15.0 1.47 (1.11 - 1.94) 1.55 (1.13 - 2.12) 1.46 (1.06 – 2.02)
 Smoker of blond tobacco only 204 23.30 182 23.90 1.14 (0.89 - 1.46) 1.23 (0.94 - 1.62) 1.23 (0.93 - 1.63)
 Smoker of both tobacco types 152 17.40 106 13.90 1.45 (1.09 - 1.94) 1.58 (1.14 - 2.17) 1.59 (1.15 – 2.20)
Current smoker <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Current smoker 391 19.50 231 15.10 1.54 (1.27 - 1.87) 1.36 (1.08 - 1.70) 1.35 (1.07 - 1.70)
 Former smoker 859 42.80 611 39.90 1.28 (1.10 - 1.48) 1.30 (1.10 - 1.55) 1.28 (1.07 - 1.53)
Ever quit smoking >6 months <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Yes 457 22.70 291 19.00 1.43 (1.19 - 1.71) 1.35 (1.10 - 1.68) 1.36 (1.10 - 1.69)
 No 793 39.50 551 36.00 1.31 (1.13 - 1.52) 1.30 (1.09 - 1.55) 1.27 (1.06 - 1.52)
Inhalation <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Mouth only 125 6.22 99 6.46 1.15 (0.86 - 1.53) 1.10 (0.80 - 1.50) 1.01 (0.73 - 1.40)
 Throat 158 7.86 108 7.05 1.33 (1.02 - 1.74) 1.48 (1.11 - 1.99) 1.43 (1.06 - 1.93)
 Chest 967 48.10 635 41.40 1.38 (1.20 - 1.60) 1.33 (1.12 - 1.58) 1.33 (1.11 - 1.59)
p-trend<0.001 p-trend<0.001 p-trend<0.001
Filter-use <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Filtered only 1042 51.90 706 46.10 1.34 (1.17 - 1.54) 1.25 (1.06 - 1.48) 1.23 (1.04 - 1.47)
 Non-filtered only 65 3.24 49 3.20 1.20 (0.82 - 1.78) 1.69 (1.10 - 2.61) 1.64 (1.05 - 2.56)
 Both 143 7.12 87 5.68 1.49 (1.12 - 1.99) 1.65 (1.21 - 2.27) 1.68 (1.21 - 2.31)
p-trend<0.001 p-trend<0.001 p-trend<0.001
Smoking cigar 0.016
 No 1797 89.40 1408 91.90 1.00 1.00 1.00
 Yes 212 10.60 124 8.09 1.34 (1.06 - 1.69) 1.00 (0.76 - 1.32) 0.98 (0.74 - 1.30)
Smoking pipe 0.001
 No 1742 86.70 1384 90.30 1.00 1.00 1.00
 Yes 267 13.30 148 9.66 1.43 (1.16 - 1.78) 1.13 (0.86 - 1.49) 1.11 (0.84 - 1.47)
Tobacco type for pipe3 <0.001
 No pipe smoker 1742 86.70 1384 90.30 1.00 1.00 1.00
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 Black 14 0.70 16 1.04 0.70 (0.33 - 1.44) 0.78 (0.37 - 1.66) 0.65 (0.29 - 1.43)
 Blond 83 4.13 62 4.05 1.06 (0.76 - 1.49) 1.25 (0.85 - 1.82) 1.29 (0.88 - 1.90)
 Mixed 170 8.46 70 4.57 1.93 (1.45 - 2.58) 1.12 (0.76 - 1.66) 1.08 (0.72 - 1.61)
Smoking status (cigarettes) <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Former 699 34.80 568 37.10 1.12 (0.96 - 1.30) 1.14 (0.95 - 1.36) 1.11 (0.93 - 1.34)
 Current 551 27.40 274 17.90 1.83 (1.53 - 2.18) 1.69 (1.37 - 2.09) 1.69 (1.37 - 2.10)
p-trend<0.001 p-trend<0.001 p-trend<0.001
Smoking status incl. occasional <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Occasional 33 1.64 42 2.74 0.72 (0.44 - 1.14) 1.00 (0.61 - 1.67) 1.05 (0.63 - 1.76)
 Former 667 33.20 530 34.60 1.14 (0.98 - 1.33) 1.14 (0.95 - 1.37) 1.11 (0.92 - 1.34)
 Current 550 27.40 270 17.60 1.85 (1.55 - 2.21) 1.72 (1.39 - 2.12) 1.72 (1.39 - 2.13)
p-trend<0.001 p-trend<0.001 p-trend<0.001
Quit smoking <10 or ≥ 10 years ago <0.001   
 Never-smoker and former smoker quit >10years 803 40.00 410 26.80 1.00 1.00 1.00
 Current smoker and former smoker quit ≤10years 1206 60.00 1122 73.20 0.55 (0.48 - 0.63) 0.64 (0.54 - 0.76) 0.64 (0.54 - 0.76)
Childhood exposure to ETS <0.001
Both parents were never-smokers 420 20.90 391 25.50 1.00 1.00 1.00
Only the father smoked 1341 66.70 908 59.30 1.37 (1.17 - 1.62) 1.25 (1.04 - 1.51) 1.24 (1.03 - 1.50)
Only the mother smoked 37 1.84 44 2.87 0.78 (0.49 - 1.24) 1.02 (0.62 - 1.70) 0.96 (0.57 - 1.62)
Both parents smoked 211 10.50 189 12.30 1.04 (0.82 - 1.32) 1.07 (0.81 - 1.42) 1.08 (0.81 - 1.45)
p-trend = 0.977 p-trend = 0.610 p-trend = 0.586
Age at smoking initiation in tertiles (years) <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 15 423 21.10 278 18.10 1.38 (1.15 - 1.66) 1.36 (1.10 - 1.70) 1.33 (1.06 - 1.66)
 15 - 18 455 22.60 299 19.50 1.38 (1.16 - 1.65) 1.31 (1.06 - 1.61) 1.31 (1.05 - 1.62)
 ≥ 18 372 18.50 265 17.30 1.28 (1.06 - 1.54) 1.29 (1.04 - 1.59) 1.26 (1.02 - 1.57)
p-trend<0.001 p-trend = 0.010 p-trend = 0.016
Age last smoked in tertiles (years) <0.001   
 Current smoker 551 27.40 274 17.90 1.00 1.00 1.00
 < 38 192 9.56 198 12.90 0.48 (0.38 - 0.62) 0.56 (0.43 - 0.74) 0.58 (0.44 - 0.77)
 38 - 50 255 12.70 193 12.60 0.66 (0.52 - 0.83) 0.71 (0.55 - 0.93) 0.69 (0.52 - 0.90)
 ≥ 50 252 12.50 177 11.60 0.71 (0.56 - 0.90) 0.76 (0.58 - 1.01) 0.72 (0.54 - 0.96)
Never-smoker 759 37.80 690 45.00  p-trend<0.001 p-trend<0.001 p-trend<0.001
Time of ever quitting in tertiles (years) <0.001
  Current smoker who never quitted 793 39.50 551 36.00 1.00 1.00 1.00
 < 2 175 8.71 108 7.05 1.13 (0.87 - 1.47) 0.93 (0.69 - 1.26) 0.96 (0.71 - 1.30)
 2 - 6 132 6.57 86 5.61 1.07 (0.80 - 1.43) 0.94 (0.68 - 1.30) 0.95 (0.68 - 1.33)
 ≥ 6 150 7.47 97 6.33 1.07 (0.81 - 1.42) 1.32 (0.96 - 1.82) 1.38 (1.00 - 1.92)
Never-smoker 759 37.80 690 45.00 p-trend = 0.020 p-trend = 0.024 p-trend = 0.015
Smoking duration in tertiles (years) <0.001
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 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 23 292 14.50 284 18.50 0.93 (0.77 - 1.13) 0.91 (0.72 - 1.14) 0.93 (0.73 - 1.17)
 23 - 35 477 23.70 281 18.30 1.54 (1.29 - 1.85) 1.52 (1.23 - 1.87) 1.48 (1.20 - 1.84)
 ≥ 35 481 23.90 277 18.10 1.58 (1.32 - 1.89) 1.51 (1.23 - 1.86) 1.47 (1.19 - 1.82)
p-trend<0.001 p-trend<0.001 p-trend<0.001
Smoking intensity in tertiles (cigarettes per day) <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 10 389 19.40 343 22.40 1.03 (0.86 - 1.23) 1.02 (0.83 - 1.25) 0.92 (0.73 - 1.16)
 10 - 20 533 26.50 287 18.70 1.69 (1.42 - 2.02) 1.64 (1.34 - 2.02) 1.55 (1.25 - 1.93)
 ≥ 20 328 16.30 212 13.80 1.41 (1.15 - 1.72) 1.41 (1.12 - 1.78) 1.44 (1.16 - 1.78)
p-trend<0.001 p-trend<0.001 p-trend<0.001
Cumulative dose in tertiles (pack-years) <0.001
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 14 279 13.90 281 18.30 0.90 (0.74 - 1.10) 0.90 (0.72 - 1.13) 1.01 (0.82 - 1.25)
 14 - 32 494 24.60 275 18.00 1.63 (1.36 - 1.96) 1.57 (1.27 - 1.94) 1.63 (1.32 - 2.01)
 ≥ 32 477 23.70 286 18.70 1.52 (1.27 - 1.81) 1.50 (1.21 - 1.84) 1.37 (1.08 - 1.74)
p-trend<0.001 p-trend<0.001 p-trend<0.001
Time since cessation in tertiles (years) <0.001   
 Current smoker 551 27.40 274 17.90 1.00 1.00 1.00
 < 14 320 15.90 191 12.50 0.83 (0.66 - 1.05) 0.81 (0.62 - 1.04) 0.78 (0.60 - 1.01)
14 - 28 229 11.40 185 12.10 0.62 (0.48 - 0.78) 0.67 (0.51 - 0.88) 0.65 (0.49 - 0.87)
≥ 28 150 7.47 192 12.50 0.39 (0.30 - 0.50) 0.49 (0.36 - 0.66) 0.49 (0.36 - 0.67)
Never-smoker 759 37.80 690 45.00  p-trend<0.001 p-trend<0.001 p-trend<0.001
Intensity of smoking cigars in tertiles (cigars per week) <0.001   
 Never-smoker 1661 82.70 1356 88.50 1.00 1.00 1.00
 < 1.0 145 7.22 68 4.44 1.74 (1.30 - 2.35) 0.95 (0.67 - 1.34) 0.96 (0.67 - 1.37)
 1.0 - 6.2 86 4.28 48 3.13 1.46 (1.02 - 2.11) 0.91 (0.59 - 1.39) 0.91 (0.59 - 1.41)
 ≥ 6.2 117 5.82 60 3.92 1.59 (1.16 - 2.20) 1.20 (0.84 - 1.73) 1.16 (0.80 - 1.69)
p-trend<0.001 p-trend = 0.571 p-trend = 0.678
Intensity of smoking pipes in tertiles (pipes per week) <0.001   
 Never-smoker 1697 84.50 1363 89.00 1.00 1.00 1.00
 < 5.0 96 4.78 58 3.79 1.33 (0.95 - 1.86) 1.13 (0.78 - 1.64) 1.12 (0.76 - 1.65)
 5.0 - 14.4 173 8.61 53 3.46 2.62 (1.92 - 3.62) 1.32 (0.89 - 1.97) 1.29 (0.85 - 1.94)
 ≥ 14.4 43 2.14 58 3.79 0.60 (0.40 - 0.89) 1.20 (0.78 - 1.85) 1.19 (0.76 - 1.85)
p-trend = 0.007 p-trend = 0.141 p-trend = 0.188
PC: pancreatic cancer; ETS: environmental tobacco smoke.
Results are shown for the categorical, imputed smoking variables. For the risk estimates of the continuous smoking variables, the unimputed data was used. The unimputed, continuous smoking 
variables and can be found in supplementary Table 5.
Model 1: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and country (Spain, England, Germany, Ireland, Italy, Sweden). Random effects model applied for country; 
Model 2: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female), country (Spain, England, Germany, Ireland, Italy, Sweden), family history of PC (yes/no) and diabetes (yes/no) 
Random effects model applied for country.
1 Chi-square test applied to evaluate differences between the groups. Significance was set at p<0.05.
2 Type of tobacco was only collected for Spain.
3 Type of pipe was not collected for Ireland.
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Supplementary Table 5. Association between smoking variables and pancreatic cancer risk in the PanGenEU study population (2,009 cases and 1,532 controls), stratified by gender, diabetes status and 
status for family history of pancreatic cancer. 
Model 1 Gender Diabetes Family history of PC
Females (N=1572)   Males (N=1969) No (N=2861)   Yes (N=680) No (N=3374)   Yes (N=167)
OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Ever smoked 100 cigarettes   
No 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Yes 1.30 (1.11 - 1.53) 1.19 (0.93 - 1.54) 1.44 (1.16 - 1.80) 1.28 (1.07 - 1.53) 1.20 (0.78 - 1.83) 1.29 (1.09 - 1.52) 1.64 (0.68 - 3.98)
p-value for interaction1  0.170 <0.001 <0.001
Regular smoker  
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Regular smoker 1.33 (1.13 - 1.57) 1.23 (0.95 - 1.58) 1.48 (1.18 - 1.85) 1.31 (1.09 - 1.57) 1.25 (0.81 - 1.91) 1.32 (1.12 - 1.56) 1.73 (0.70 - 4.24)
 Occasional smoker 1.01 (0.61 - 1.68) 0.93 (0.39 - 2.24) 1.13 (0.61 - 2.12) 1.20 (0.69 - 2.09) 0.54 (0.15 - 1.99) 1.04 (0.62 - 1.75) 0.11 (0.00 - 30.94)
p-value for interaction  0.398 <0.001 <0.001
Tobacco type2   
 Never-smoker 1.00 1.00  1.00  1.00  1.00  1.00  1.00  
 Smoker of black tobacco only 1.55 (1.13 - 2.12) 0.99 (0.46 - 2.10) 1.73 (1.20 - 2.51) 1.62 (1.13 - 2.34) 1.12 (0.57 - 2.19) 1.62 (1.18 - 2.24) 0.55 (0.10 - 3.12)
 Smoker of blond tobacco only 1.23 (0.94 - 1.62) 1.23 (0.83 - 1.82) 1.23 (0.84 - 1.80) 1.20 (0.88 - 1.64) 1.23 (0.66 - 2.29) 1.29 (0.98 - 1.70) 1.32 (0.24 - 7.40)
 Smoker of both tobacco types 1.58 (1.14 - 2.17) 1.02 (0.52 - 1.98) 1.77 (1.20 - 2.61) 1.67 (1.16 - 2.41) 1.34 (0.64 - 2.82) 1.57 (1.13 - 2.18) 1.35 (0.19 - 9.81)
p-value for interaction   0.309 <0.001 <0.001
Current smoker
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Current smoker 1.36 (1.08 - 1.70) 1.39 (0.96 - 2.00) 1.42 (1.06 - 1.91) 1.52 (1.18 - 1.95) 0.62 (0.34 - 1.13) 1.35 (1.07 - 1.70) 1.84 (0.48 - 6.99)
 Former smoker 1.30 (1.10 - 1.55) 1.14 (0.87 - 1.50) 1.48 (1.17 - 1.86) 1.23 (1.01 - 1.49) 1.44 (0.92 - 2.25) 1.29 (1.08 - 1.54) 1.58 (0.62 - 4.06)
p-value for interaction 0.208 <0.001 <0.001
Ever quit smoking >6 months
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Yes 1.35 (1.10 - 1.68) 1.22 (0.87 - 1.73) 1.51 (1.14 - 1.99) 1.29 (1.02 - 1.64) 1.78 (0.98 - 3.25) 1.37 (1.10 - 1.70) 1.05 (0.30 - 3.65)
 No 1.30 (1.09 - 1.55) 1.21 (0.91 - 1.60) 1.44 (1.14 - 1.82) 1.31 (1.08 - 1.60) 1.03 (0.66 - 1.61) 1.28 (1.06 - 1.53) 1.97 (0.74 - 5.20)
p-value for interaction 0.385 <0.001 <0.001
Inhalation
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Mouth only 1.10 (0.80 - 1.50) 0.84 (0.52 - 1.36) 1.44 (0.93 - 2.22) 0.90 (0.62 - 1.31) 1.38 (0.69 - 2.77) 1.02 (0.74 - 1.41) 5.83 (0.66 - 51.52)
 Throat 1.48 (1.11 - 1.99) 1.71 (1.11 - 2.63) 1.40 (0.93 - 2.11) 1.44 (1.03 - 2.00) 1.27 (0.63 - 2.54) 1.54 (1.14 - 2.07) 0.64 (0.13 - 3.19)
 Chest 1.33 (1.12 - 1.58) 1.20 (0.90 - 1.60) 1.47 (1.17 - 1.85) 1.36 (1.12 - 1.65) 1.13 (0.71 - 1.79) 1.32 (1.10 - 1.58) 1.61 (0.60 - 4.34)
p-value for interaction 0.173 <0.001 <0.001
Filter-use
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Filtered only 1.25 (1.06 - 1.48) 1.24 (0.96 - 1.60) 1.34 (1.06 - 1.69) 1.25 (1.04 - 1.51) 1.09 (0.70 - 1.68) 1.25 (1.05 - 1.48) 1.38 (0.56 - 3.42)
 Non-filtered only 1.69 (1.10 - 2.61) 0.76 (0.24 - 2.41) 2.01 (1.24 - 3.25) 1.81 (1.11 - 2.94) 0.97 (0.37 - 2.55) 1.54 (0.99 - 2.41) ### (0.00 - Inf)
 Both 1.65 (1.21 - 2.27) 1.01 (0.37 - 2.78) 1.87 (1.32 - 2.66) 1.50 (1.05 - 2.14) 2.26 (1.05 - 4.86) 1.66 (1.2 - 2.28) 2.74 (0.29 - 25.66)
p-value for interaction 0.222 <0.001 <0.001
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Smoking cigar
 No 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Yes 1.00 (0.76 - 1.32) 0.58 (0.17 - 1.92) 1.03 (0.78 - 1.36) 1.02 (0.74 - 1.40) 0.73 (0.41 - 1.29) 0.99 (0.75 - 1.31) 0.69 (0.18 - 2.63)
p-value for interaction 0.402 <0.001 <0.001
Smoking pipe
 No 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Yes 1.13 (0.86 - 1.49) 2.37 (0.70 - 8.00) 1.04 (0.79 - 1.39) 1.09 (0.80 - 1.48) 1.07 (0.55 - 2.07) 1.17 (0.88 - 1.55) 0.49 (0.12 - 2.01)
p-value for interaction 0.274 <0.001 <0.001
Tobacco type for pipe3
 No pipe smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Black 0.78 (0.37 - 1.66) 0.70 (0.07 - 6.81) 0.78 (0.36 - 1.66) 0.75 (0.29 - 1.95) 0.46 (0.12 - 1.84) 0.81 (0.37 - 1.77) 0.35 (0.02 - 6.83)
 Blond 1.25 (0.85 - 1.82) 4.84 (0.91 - 25.8) 1.21 (0.82 - 1.79) 1.23 (0.81 - 1.88) 1.29 (0.50 - 3.33) 1.27 (0.86 - 1.87) ### (0.00 - Inf)
 Mixed 1.12 (0.76 - 1.66) 1.03 (0.71 - 1.50) 0.96 (0.63 - 1.45) 1.03 (0.66 - 1.61) 1.29 (0.46 - 3.63) 1.16 (0.77 - 1.75) 0.20 (0.03 - 1.26)
p-value for interaction 0.158 <0.001 <0.001
Smoking status (cigarettes)
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Former 1.14 (0.95 - 1.36) 0.86 (0.64 - 1.16) 1.37 (1.08 - 1.73) 1.04 (0.85 - 1.27) 1.44 (0.91 - 2.28) 1.12 (0.93 - 1.35) 1.38 (0.52 - 3.70)
 Current 1.69 (1.37 - 2.09) 1.96 (1.40 - 2.73) 1.67 (1.26 - 2.20) 1.89 (1.50 - 2.38) 0.83 (0.48 - 1.42) 1.69 (1.37 - 2.09) 2.24 (0.66 - 7.61)
p-value for interaction 0.006 <0.001 <0.001
Smoking status incl. occasional
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Occasional 1.00 (0.61 - 1.67) 0.90 (0.38 - 2.17) 1.13 (0.61 - 2.12) 1.19 (0.69 - 2.07) 0.55 (0.15 - 2.05) 1.04 (0.62 - 1.74) 0.11 (0.00 - 3.75)
 Former 1.14 (0.95 - 1.37) 0.85 (0.63 - 1.16) 1.37 (1.08 - 1.75) 1.03 (0.84 - 1.26) 1.52 (0.95 - 2.43) 1.12 (0.93 - 1.35) 1.49 (0.55 - 4.05)
 Current 1.72 (1.39 - 2.12) 1.98 (1.42 - 2.77) 1.69 (1.28 - 2.23) 1.91 (1.52 - 2.41) 0.86 (0.50 - 1.48) 1.71 (1.38 - 2.12) 2.25 (0.66 - 7.69)
p-value for interaction 0.016 <0.001 <0.001
Quit smoking <10 or ≥ 10 years ago   
 Never-smoker and former smoker quit >10years 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 Current smoker and former smoker quit ≤10years 0.64 (0.54 - 0.76) 0.55 (0.41 - 0.72) 0.69 (0.56 - 0.85) 0.58 (0.48 - 0.71) 1.10 (0.72 - 1.68) 0.64 (0.54 - 0.76) 0.47 (0.17 - 1.31)
p-value for interaction 0.193 <0.001 <0.001
Childhood exposure to ETS
Both parents were never-
smokers 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
Only the father smoked 1.25 (1.04 - 1.51) 1.36 (1.02 - 1.80) 1.18 (0.92 - 1.52) 1.24 (1.01 - 1.53) 1.21 (0.78 - 1.90) 1.23 (1.02 - 1.49) 1.75 (0.59 - 5.22)
Only the mother smoked 1.02 (0.62 - 1.70) 0.95 (0.44 - 2.05) 1.06 (0.53 - 2.12) 1.00 (0.57 - 1.73) 1.08 (0.24 - 4.83) 0.90 (0.53 - 1.55) 3.29 (0.23 - 46.93)
Both parents smoked 1.07 (0.81 - 1.42) 1.23 (0.80 - 1.91) 0.96 (0.66 - 1.39) 1.11 (0.82 - 1.51) 1.04 (0.41 - 2.66) 1.11 (0.83 - 1.48) 0.28 (0.05 - 1.49)
p-value for interaction 0.785 <0.001 <0.001
Age at smoking initiation in tertiles (years)
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 15 1.38 (1.15 - 1.66) 0.95 (0.6 - 1.50) 1.56 (1.20 - 2.04) 1.38 (1.08 - 1.76) 0.95 (0.55 - 1.65) 1.41 (1.12 - 1.76) 0.52 (0.15 - 1.83)
 15 - 18 1.38 (1.16 - 1.65) 1.04 (0.74 - 1.47) 1.53 (1.16 - 2.01) 1.35 (1.07 - 1.70) 0.99 (0.57 - 1.72) 1.27 (1.03 - 1.58) 2.01 (0.58 - 6.97)
 ≥ 18 1.28 (1.06 - 1.54) 1.47 (1.08 - 2.02) 1.24 (0.92 - 1.67) 1.20 (0.95 - 1.53) 1.70 (0.97 - 2.97) 1.26 (1.01 - 1.56) 3.48 (0.91 - 13.28)
p-value for interaction 0.049 <0.001 <0.001






























































PanGenEU: Smoking & PC risk – Supplementary Material (02 05 2019) 15
Age last smoked in tertiles (years)   
 Current smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 38 0.48 (0.38 - 0.62) 0.24 (0.14 - 0.41) 0.79 (0.57 - 1.10) 0.49 (0.36 - 0.66) 2.06 (0.85 - 4.96) 0.55 (0.42 - 0.73) 0.64 (0.13 - 3.16)
 38 - 50 0.66 (0.52 - 0.83) 0.56 (0.34 - 0.91) 0.81 (0.58 - 1.11) 0.56 (0.41 - 0.76) 1.63 (0.86 - 3.10) 0.72 (0.54 - 0.94) 0.66 (0.12 - 3.63)
 ≥ 50 0.71 (0.56 - 0.90) 0.64 (0.38 - 1.06) 0.87 (0.62 - 1.21) 0.64 (0.46 - 0.87) 1.72 (0.91 - 3.25) 0.75 (0.56 - 0.99) 0.57 (0.12 - 2.70)
Never-smoker 0.55 (0.46 - 0.65) 0.53 (0.38 - 0.74) 0.60 (0.46 - 0.79) 0.53 (0.42 - 0.67) 1.21 (0.70 - 2.08) 0.60 (0.48 - 0.74) 0.44 (0.13 - 1.51)
p-value for interaction 0.001 <0.001 <0.001
Time of ever quitting in tertiles (years)
 Current smoker who never quitted 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 2 1.13 (0.87 - 1.47) 1.09 (0.65 - 1.84) 0.85 (0.59 - 1.23) 0.87 (0.63 - 1.21) 2.89 (0.95 - 8.79) 0.95 (0.70 - 1.29) 0.50 (0.11 - 2.22)
 2 - 6 1.07 (0.80 - 1.43) 0.74 (0.42 - 1.30) 1.08 (0.71 - 1.63) 0.92 (0.64 - 1.32) 1.21 (0.50 - 2.91) 0.99 (0.71 - 1.38) 0.32 (0.05 - 2.21)
 ≥ 6 1.07 (0.81 - 1.42) 1.29 (0.73 - 2.27) 1.30 (0.88 - 1.93) 1.24 (0.87 - 1.79) 1.68 (0.74 - 3.82) 1.32 (0.96 - 1.84) ### (0.00 - Inf)
Never-smoker 0.76 (0.66 - 0.89) 0.83 (0.63 - 1.10) 0.70 (0.55 - 0.88) 0.76 (0.63 - 0.93) 0.96 (0.61 - 1.50) 0.78 (0.65 - 0.94) 0.52 (0.20 - 1.37)
p-value for interaction 0.412 <0.001 <0.001
Smoking duration in tertiles (years)
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 23 0.93 (0.77 - 1.13) 0.57 (0.39 - 0.84) 1.20 (0.89 - 1.61) 0.87 (0.67 - 1.12) 1.27 (0.66 - 2.45) 0.89 (0.70 - 1.13) 1.91 (0.50 - 7.30)
 23 - 35 1.54 (1.29 - 1.85) 1.59 (1.13 - 2.23) 1.57 (1.19 - 2.06) 1.47 (1.17 - 1.86) 1.43 (0.82 - 2.48) 1.53 (1.23 - 1.90) 1.24 (0.35 - 4.41)
 ≥ 35 1.58 (1.32 - 1.89) 1.72 (1.19 - 2.47) 1.58 (1.21 - 2.06) 1.60 (1.26 - 2.02) 1.02 (0.62 - 1.68) 1.48 (1.20 - 1.84) 1.79 (0.59 - 5.42)
p-value for interaction 0.007 <0.001 <0.001
Smoking intensity in tertiles (cigarettes per day)   
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 10 1.03 (0.86 - 1.23) 0.93 (0.68 - 1.27) 1.15 (0.86 - 1.54) 1.00 (0.79 - 1.26) 1.01 (0.60 - 1.71) 0.98 (0.79 - 1.21) 2.93 (0.76 - 11.28)
 10 - 20 1.69 (1.42 - 2.02) 1.85 (1.31 - 2.62) 1.64 (1.25 - 2.14) 1.64 (1.31 - 2.06) 1.47 (0.84 - 2.57) 1.65 (1.33 - 2.04) 1.84 (0.57 - 5.94)
 ≥ 20 1.41 (1.15 - 1.72) 1.06 (0.65 - 1.73) 1.61 (1.21 - 2.13) 1.40 (1.08 - 1.82) 1.21 (0.68 - 2.13) 1.44 (1.13 - 1.83) 0.73 (0.21 - 2.57)
p-value for interaction 0.271 <0.001 <0.001
Cumulative dose in tertiles (pack-years)
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 14 0.90 (0.74 - 1.10) 0.82 (0.58 - 1.16) 1.01 (0.74 - 1.37) 0.91 (0.70 - 1.17) 0.94 (0.51 - 1.73) 0.88 (0.69 - 1.11) 2.12 (0.56 - 8.03)
 14 - 32 1.63 (1.36 - 1.96) 1.50 (1.06 - 2.11) 1.70 (1.29 - 2.23) 1.52 (1.20 - 1.92) 1.56 (0.89 - 2.73) 1.57 (1.27 - 1.95) 1.52 (0.45 - 5.15)
 ≥ 32 1.52 (1.27 - 1.81) 1.53 (1.04 - 2.25) 1.59 (1.22 - 2.07) 1.51 (1.20 - 1.91) 1.13 (0.68 - 1.89) 1.48 (1.20 - 1.84) 1.44 (0.45 - 4.57)
p-value for interaction 0.681 <0.001 <0.001
Time since cessation in tertiles (years)   
 Current smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 14 0.83 (0.66 - 1.05) 0.62 (0.40 - 0.97) 0.93 (0.68 - 1.27) 0.67 (0.50 - 0.89) 1.94 (1.02 - 3.69) 0.81 (0.62 - 1.05) 0.43 (0.09 - 1.98)
14 - 28 0.62 (0.48 - 0.78) 0.43 (0.26 - 0.71) 0.82 (0.59 - 1.14) 0.56 (0.41 - 0.76) 1.64 (0.84 - 3.19) 0.66 (0.50 - 0.87) 0.79 (0.16 - 3.84)
≥ 28 0.39 (0.30 - 0.50) 0.21 (0.11 - 0.39) 0.66 (0.46 - 0.94) 0.39 (0.28 - 0.55) 1.55 (0.74 - 3.26) 0.47 (0.34 - 0.64) 0.74 (0.13 - 4.38)
Never-smoker 0.55 (0.46 - 0.65) 0.50 (0.36 - 0.70) 0.59 (0.45 - 0.78) 0.52 (0.41 - 0.66) 1.21 (0.70 - 2.07) 0.58 (0.47 - 0.72) 0.45 (0.13 - 1.54)
p-value for interaction 0.005 <0.001 <0.001
Intensity of smoking cigars in tertiles (cigars per week)
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 1.0 1.74 (1.30 - 2.35) 1 (0.48 - 1.76) 0.96 (0.63 - 1.46) 0.94 (0.63 - 1.41) 1.14 (0.49 - 2.66) 0.96 (0.66 - 1.38) 0 (0.09 - 2.39)
 1.0 - 6.2 1.46 (1.02 - 2.11) 0.57 (0.11 - 2.82) 0.94 (0.60 - 1.47) 1.21 (0.72 - 2.02) 0.34 (0.15 - 0.76) 0.87 (0.56 - 1.35) ### (0.00 - Inf)
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 ≥ 6.2 1.59 (1.16 - 2.20) 0.36 (0.06 - 2.10) 1.27 (0.88 - 1.84) 1.06 (0.69 - 1.61) 1.59 (0.66 - 3.86) 1.26 (0.86 - 1.83) 0.30 (0.07 - 1.27)
p-value for interaction 0.552 <0.001 <0.001
Intensity of smoking pipes in tertiles (pipes per week)
 Never-smoker 1.00 1.00 1.00 1.00 1.00 1.00 1.00  
 < 5.0 1.33 (0.95 - 1.86) 2.03 (0.77 - 5.36) 1.01 (0.67 - 1.52) 1.22 (0.79 - 1.89) 0.75 (0.35 - 1.62) 1.14 (0.78 - 1.66) ### (0 - Inf)
 5.0 – 14.4 2.62 (1.92 - 3.62) 1.11 (0.19 - 6.60) 1.28 (0.85 - 1.93) 1.20 (0.77 - 1.88) 2.32 (0.73 - 7.36) 1.34 (0.88 - 2.03) 0.57 (0.09 - 3.44)
 ≥ 14.4 0.60 (0.40 - 0.89) 2.38 (0.15 - 38.63) 1.10 (0.70 - 1.73) 1.13 (0.69 - 1.85) 1.29 (0.41 - 4.02) 1.32 (0.84 - 2.06) 0.16 (0.02 - 1.62)
p-value for interaction 0.562 <0.001 <0.001
Smoking duration (years) 1.01 (1.01 - 1.01) 1.27 (1.12 - 1.44) 1.21 (1.09 - 1.35) 1.24 (1.13 - 1.36) 1.02 (0.83 - 1.25) 1.22 (1.12 - 1.33) 1.33 (0.80 - 2.23)
p-value for interaction  0.426 <0.001 <0.001
Smoking intensity (cigs/day) 1.01 (1.00 - 1.01) 1.10 (0.98 - 1.24) 1.17 (1.06 - 1.30) 1.15 (1.05 - 1.25) 1.01 (0.83 - 1.24) 1.15 (1.06 - 1.25) 0.82 (0.54 - 1.26)
p-value for interaction  0.984 <0.001 <0.001
Cumulative dose (pack-years) 1.01 (1.00 - 1.01) 1.20 (1.06 - 1.36) 1.20 (1.08 - 1.34) 1.22 (1.11 - 1.34) 0.97 (0.80 - 1.18) 1.19 (1.10 - 1.30) 0.88 (0.55 - 1.39)
p-value for interaction  0.161 <0.001 <0.001
Time since cessation (years) 0.98 (0.97 - 0.99) 0.50 (0.39 - 0.63) 0.87 (0.76 - 1.00) 0.69 (0.60 - 0.78) 1.10 (0.83 - 1.44) 0.74 (0.66 - 0.84) 0.99 (0.52 - 1.90)
p-value for interaction 0.001 <0.001 <0.001
Age at smoking initiation (years) 1.01 (1.00 - 1.02) 1.09 (0.97 - 1.23) 1.12 (1.02 - 1.24) 1.10 (1.01 - 1.19) 1.08 (0.89 - 1.30) 1.09 (1.01 - 1.18) 1.35 (0.88 - 2.09)
p-value for interaction 0.410 <0.001 <0.001
Age last smoked (years) 1.01 (1.00 - 1.01) 1.17 (1.04 - 1.31) 1.13 (1.02 - 1.25) 1.09 (1.00 - 1.19) 1.25 (1.02 - 1.52) 1.13 (1.04 - 1.22) 1.33 (0.84 - 2.11)
p-value for interaction 0.658 <0.001 <0.001
Time of ever quitting (years) 1.00 (0.98 - 1.03) 1.01 (0.89 - 1.15) 1.01 (0.91 - 1.12) 0.99 (0.91 - 1.09) 1.12 (0.88 - 1.44) 1.02 (0.94 - 1.10) 0.97 (0.50 - 1.86)
p-value for interaction 0.899 <0.001 <0.001
Intensity of smoking cigars 
(cigars per week) 1.00 (0.98 - 1.02) 0.98 (0.86 - 1.11) 1.04 (0.94 - 1.15) 0.98 (0.90 - 1.07) 1.17 (0.86 - 1.60) 1.04 (0.95 - 1.12) 0.72 (0.49 - 1.07)
p-value for interaction 0.696 <0.001 <0.001
Intensity of smoking pipes 
(pipes per week) 1.00 (0.98 - 1.01) 1.19 (0.78 - 1.81) 0.99 (0.89 - 1.10) 0.99 (0.90 - 1.08) 1.07 (0.87 - 1.33) 1.02 (0.94 - 1.11) 0.68 (0.44 - 1.04)
p-value for interaction 0.108 <0.001 <0.001
PC: pancreatic cancer; ETS: environmental tobacco smoke.
Results are shown for the categorical, imputed smoking variables, and for the continuous, unimputed smoking variables.
Model 1: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and country (Spain, England, Germany, Ireland, Italy, Sweden).
For the stratified analysis by gender, the model was only adjusted for age and country, for the stratified analysis by age, the model was only adjusted by gender and country.
1 Interaction by covariate (gender, diabetes, family history of PC).
2 Type of tobacco was only collected for Spain (N=1,638). Numbers for gender: N=733 females, N=905 males; diabetes: N=1,234 no, N=404 yes; and family history of PC: N=1,554 no, N=84 yes.   
3 Type of pipe was not collected for Ireland.
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Supplementary Table 6: Combined effects of smoking duration and tobacco type on pancreatic cancer risk in the PanGenEU-Spain study 
population (876 cases and 762 controls).
Smoking duration of blond tobacco (years)

















Never-smoker 1.00 355/360 1.03 (0.65 - 1.64) 42/47 1.27 (0.81 - 2.00) 51/45 1.33 (0.95 - 1.84) 112/90
<20 years 1.37 (0.71 - 2.64) 25/17 0.84 (0.66 - 1.07) 25/32 0.93 (0.52 - 1.67) 10/8 1.43 (0.54 - 3.76) 6/5

















   
≥ 30 years 1.58 (1.11 - 2.27) 109/76 1.86 (0.84 - 4.13) 18/11 1.83  (0.79 - 4.26) 15/10 2.05  (1.25 - 3.36) 56/31
Risk estimates are shown for the imputed smoking variables.
Adjusted OR for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and region (East, Central and Northern Spain).
Relative excess risk due to interaction = RERI=0.206, 95%CI: -0.49 - 0.91.
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Supplementary Table 7: Non-linear association between continuous smoking variables and pancreatic cancer risk per 1-unit increase in the variables for the PanGenEU study 
population (2,009 cases and 1,532 controls).
Fractional polynomials aOR (95% CI) per 1-unit increaseRestricted
Cubic splines Model 1 Model 2 Model 3
LR test1
p-value Formula resulting from the fractional polynomials2 aOR (95%CI) aOR (95%CI) aOR (95%CI)
Age at smoking initiation (years) 0.031  (smoke first + 110 )
-2
1.11 (1.04 - 1.20) 1.00 (0.89 - 1.11) 0.96 (0.87 - 1.07)
Age last smoked (years) 0.008  (smoke last + 110 )
0.5
+ ((smoke last + 0.110 )0.5 * log (smoke last + 0.110 )) 1.07 (1.04 - 1.10) 1.05 (1.00 - 1.11) 0.99 (0.93 - 1.06)
Smoking duration (years) 0.020  (duration + 0.110 )
3
+ ((duration + 0.110 )3 * log (duration + 0.110 )) 1.04 (1.02 - 1.05) 1.03 (1.02 - 1.05) N.A.
Smoking intensity (cigarettes per day) 0.001  (intensity + 0.210 )
0.5
1.29 (1.18 - 1.45) N.A. 1.04 (0.88 - 1.23)
Cumulative dose (pack-years) 0.000  (pack - years + 0.110 )
0.5
1.24 (1.16 - 1.35) N.A. N.A.
Time since cessation (years)3 0.016  (cessation + 110 )
1
+ (cessation + 110 )
3
0.81 (0.74 - 0.88) 0.80 (0.72 - 0.87) 0.89 (0.71 - 1.05)
Time since cessation (years) 
for PanGenEU – Spain3,4 0.073  (cessation + 110 )
1
+  (cessation + 110 )
31
0.85 (0.74 - 0.96) 0.85 (0.73 - 0.96) 0.88 (0.66 - 1.11)
PC: pancreatic cancer; N.A.: not applicable.
Risk estimates are shown for the unimputed continuous smoking variables.
Model 1: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and country (Spain, England, Germany, Ireland, Italy, Sweden);
Model 2: Model 1 plus additional adjustment for smoking intensity (cigarettes per day, continuous, non-linear); 
Model 3: Model 1 plus additional adjustment for smoking duration (years, continuous, non-linear).
1 Likelihood ratio test (LR test) comparing two models, adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female), and country (Spain, England, Germany, Ireland, Italy, Sweden), with and without restricted cubic splines 
applied (knots at 10, 50 and 90%).
2 Fractional polynomials adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female), and country (Spain, England, Germany, Ireland, Italy, Sweden).
3 Never-smokers were removed from time since cessation variables.
4 The PanGenEU-Spain study population consists of 876 cases and 762 controls. The model was adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and region (East, Central and Northern Spain).
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Supplementary Table 8. Association between smoking variables and pancreatic cancer risk in the PanGenEU study population (2,009 cases and 1,532 controls) before 
imputation.
 Unadjusted Model 1 Model 2
Cases, % Controls, % p-value1 OR (95%CI) OR (95%CI) OR (95%CI)
Ever smoked 100 cigarettes <0.001   
No 764 38.00 691 45.10 1.00 1.00 1.00
 Yes 1234 61.40 840 54.80 1.33 (1.16 - 1.52) 1.32 (1.12 - 1.55) 1.28 (1.08 - 1.51)
 Missing 11 0.55 1 0.07   
Regular smoker <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Regular smoker 1144 56.90 792 51.70 1.31 (1.14 - 1.51) 1.34 (1.14 - 1.58) 1.30 (1.09 - 1.53)
 Occasional smoker 27 1.34 42 2.74 0.59 (0.35 - 0.96) 0.81 (0.47 - 1.39) 0.83 (0.48 - 1.45)
 Missing 79 3.93 8 0.52   
Tobacco type2     0.003     
 Never-smoker 355 40.50 360 47.20 1.00 1.00 1.00
 Smoker of black tobacco only 165 18.80 114 15.00 1.47 (1.11 - 1.94) 1.56 (1.14 - 2.14) 1.46 (1.05 – 2.02)
 Smoker of blond tobacco only 191 21.80 179 23.50 1.08 (0.84 - 1.39) 1.17 (0.89 - 1.54) 1.15 (0.86 - 1.53)
 Smoker of both tobacco types 152 17.40 106 13.90 1.45 (1.09 - 1.94) 1.58 (1.15 - 2.18) 1.56 (1.12 – 2.17)
 Missing 13 1.50 3 0.40     
Current smoker <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Current smoker 391 19.50 231 15.10 1.54 (1.27 - 1.87) 1.38 (1.10 - 1.74) 1.34 (1.06 - 1.69)
 Former smoker 819 40.80 582 38.00 1.28 (1.10 - 1.48) 1.32 (1.11 - 1.57) 1.28 (1.07 - 1.53)
 Missing 40 1.99 29 1.89   
Ever quit smoking >6 months <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Yes 322 16.00 203 13.30 1.44 (1.18 - 1.77) 1.33 (1.04 - 1.68) 1.34 (1.05 - 1.72)
 No 793 39.50 551 36.00 1.31 (1.13 - 1.52) 1.35 (1.13 - 1.61) 1.29 (1.07 - 1.55)
 Missing 135 6.72 88 5.74   
Inhalation <0.001   
 Never-smoker 730 36.30 663 43.30 1.00 1.00 1.00
 Mouth only 108 5.38 98 6.40 1.00 (0.75 - 1.34) 1.08 (0.79 - 1.49) 0.98 (0.70 - 1.37)
 Throat 155 7.72 107 6.98 1.31 (1.01 - 1.72) 1.55 (1.16 - 2.08) 1.54 (1.13 - 2.08)
 Chest 765 38.10 574 37.50 1.21 (1.04 - 1.41) 1.39 (1.16 - 1.67) 1.35 (1.12 - 1.63)
Missing 251 12.50 90 5.87 p-trend<0.001 p-trend<0.001 p-trend<0.001
Filter-use <0.001   
 Never-smoker 730 36.30 663 43.30 1.00 1.00 1.00
 Filtered only 786 39.10 639 41.70 1.12 (0.96 - 1.30) 1.20 (1.00 - 1.43) 1.16 (0.96 - 1.39)
 Non-filtered only 62 3.09 49 3.20 1.15 (0.78 - 1.70) 1.70 (1.09 - 2.64) 1.62 (1.03 - 2.56)
 Both 137 6.82 82 5.35 1.52 (1.13 - 2.04) 1.73 (1.25 - 2.39) 1.72 (1.23 - 2.41)
Missing 294 14.60 99 6.46 p-trend = 0.004 p-trend<0.001 p-trend<0.001
Smoking cigar <0.001   
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 No 1519 75.60 1325 86.50 1.00 1.00 1.00
 Yes 138 6.87 122 7.96 0.99 (0.76 - 1.27) 0.96 (0.73 - 1.27) 0.89 (0.66 - 1.19)
 Missing 352 17.50 85 5.55   
Smoking pipe <0.001   
 No 1520 75.70 1306 85.20 1.00 1.00 1.00
 Yes 132 6.57 144 9.40 0.79 (0.61 - 1.01) 1.11 (0.84 - 1.47) 1.08 (0.81 - 1.46)
 Missing 357 17.80 82 5.35   
Tobacco type for pipe3 <0.001   
 No pipe smoker 1467 73.00 1259 82.20 1.00 1.00 1.00
 Black 12 0.60 9 0.59 1.14 (0.48 - 2.83) 1.40 (0.55 - 3.55) 1.11 (0.39 - 3.19)
 Blond 41 2.04 41 2.68 0.86 (0.55 - 1.34) 1.06 (0.66 - 1.70) 1.14 (0.69 - 1.87)
 Mixed 42 2.09 39 2.55 0.92 (0.59 - 1.44) 1.26 (0.76 - 2.11) 1.20 (0.70 - 2.08)
 Missing 447 22.20 184 12.00   
Smoking status (cigarettes) <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Former 630 31.40 528 34.50 1.08 (0.93 - 1.27) 1.14 (0.95 - 1.36) 1.10 (0.91 - 1.33)
 Current 548 27.30 273 17.80 1.82 (1.53 - 2.18) 1.72 (1.40 - 2.12) 1.67 (1.35 - 2.08)
Missing 72 3.58 41 2.68 p-trend<0.001 p-trend<0.001 p-trend<0.001
Smoking status incl. occasional <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 Occasional 27 1.34 42 2.74 0.59 (0.35 - 0.96) 0.80 (0.47 - 1.38) 0.83 (0.47 - 1.44)
 Former 610 30.40 512 33.40 1.08 (0.93 - 1.27) 1.13 (0.94 - 1.36) 1.09 (0.90 - 1.32)
 Current 547 27.20 269 17.60 1.85 (1.55 - 2.21) 1.74 (1.41 - 2.14) 1.69 (1.36 - 2.10)
Missing 66 3.29 19 1.24 p-trend<0.001 p-trend<0.001 p-trend<0.001
Quit smoking <10 or ≥ 10 years ago <0.001   
 Never-smoker and former smoker quit >10years 1169 58.20 1090 71.10 1.00 1.00 1.00
 Current smoker and former smoker quit ≤10years 740 36.80 398 26.00 1.73 (1.50 - 2.01) 1.57 (1.32 - 1.86) 1.53 (1.28 - 1.83)
 Missing 100 4.98 44 2.87   
Childhood exposure to ETS <0.001   
Both parents were never-smokers 413 20.60 389 25.40 1.00 1.00 1.00
Only the father smoked 995 49.50 762 49.70 1.23 (1.04 - 1.45) 1.12 (0.92 - 1.35) 1.11 (0.91 - 1.36)
Only the mother smoked 37 1.84 44 2.87 0.79 (0.50 - 1.25) 1.19 (0.71 - 2.00) 1.11 (0.65 - 1.88)
Both parents smoked 194 9.66 170 11.10 1.07 (0.84 - 1.38) 1.34 (0.99 - 1.82) 1.34 (0.98 - 1.83)
Missing 370 18.40 167 10.90 p-trend = 0.734 p-trend = 0.056 p-trend = 0.068
Age at smoking initiation in tertiles (years) <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 16 550 27.40 352 23.00 1.42 (1.20 - 1.68) 1.42 (1.16 - 1.74) 1.35 (1.10 - 1.67)
 16 - 18 289 14.40 189 12.30 1.39 (1.13 - 1.72) 1.26 (0.98 - 1.61) 1.19 (0.92 - 1.54)
 ≥ 18 372 18.50 265 17.30 1.28 (1.06 - 1.54) 1.34 (1.08 - 1.65) 1.32 (1.06 - 1.65)
Missing 39 1.94 36 2.35 p-trend = 0.002 p-trend = 0.026 p-trend = 0.036
Age last smoked in tertiles (years) <0.001   
 Never-smoker 776 38.60 700 45.70 1.00 1.00 1.00
 < 37 188 9.36 202 13.20 0.84 (0.67 - 1.05) 0.78 (0.60 - 1.02) 0.82 (0.62 - 1.07)
 37 - 52 318 15.80 214 14.00 1.34 (1.10 - 1.64) 1.34 (1.06 - 1.69) 1.28 (1.00 - 1.63)
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 ≥ 52 346 17.20 197 12.90 1.58 (1.29 - 1.94) 1.62 (1.29 - 2.03) 1.55 (1.22 - 1.97)
Missing 381 19.00 219 14.30 p-trend<0.001 p-trend<0.001 p-trend<0.001
Time of ever quitting in tertiles (years) 0.069   
  Current smoker 1552 77.30 1241 81.00 1.00 1.00 1.00
 < 1.3 104 5.18 65 4.24 1.28 (0.93 - 1.77) 0.96 (0.66 - 1.40) 1.02 (0.69 - 1.51)
 1.3 - 3.9 83 4.13 62 4.05 1.07 (0.76 - 1.50) 1.07 (0.74 - 1.55) 1.07 (0.72 - 1.57)
 ≥ 3.9 102 5.08 66 4.31 1.23 (0.90 - 1.71) 1.25 (0.87 - 1.78) 1.27 (0.88 - 1.84)
 Missing 168 8.36 98 6.40 p-trend = 0.117 p-trend = 0.402 p-trend = 0.320
Smoking duration in tertiles (years) <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 22 227 11.30 238 15.50 0.87 (0.70 - 1.07) 0.92 (0.72 - 1.18) 0.93 (0.72 - 1.21)
 22 - 37 390 19.40 255 16.60 1.39 (1.15 - 1.68) 1.40 (1.12 - 1.75) 1.36 (1.08 - 1.70)
 ≥ 37 421 21.00 228 14.90 1.68 (1.39 - 2.03) 1.69 (1.36 - 2.10) 1.58 (1.26 - 1.99)
Missing 212 10.60 121 7.90 p-trend<0.001 p-trend<0.001 p-trend<0.001
Smoking intensity in tertiles (cigarettes per day) <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 10 353 17.60 308 20.10 1.04 (0.87 - 1.25) 1.03 (0.83 - 1.27) 1.01 (0.81 - 1.26)
 10 - 20 505 25.10 276 18.00 1.66 (1.39 - 1.99) 1.66 (1.34 - 2.04) 1.62 (1.31 - 2.02)
 ≥ 20 328 16.30 212 13.80 1.41 (1.15 - 1.72) 1.47 (1.17 - 1.86) 1.38 (1.08 - 1.76)
Missing 64 3.19 46 3.00 p-trend<0.001 p-trend<0.001 p-trend<0.001
Cumulative dose in tertiles (pack-years) <0.001   
 Never-smoker 759 37.80 690 45.00 1.00 1.00 1.00
 < 13 234 11.60 235 15.30 0.91 (0.73 - 1.12) 0.95 (0.74 - 1.22) 0.96 (0.75 - 1.24)
 13 - 36 401 20.00 239 15.60 1.52 (1.26 - 1.85) 1.57 (1.26 - 1.97) 1.53 (1.22 - 1.93)
 ≥ 36 392 19.50 235 15.30 1.52 (1.25 - 1.84) 1.59 (1.28 - 1.99) 1.47 (1.17 - 1.85)
Missing 223 11.10 133 8.68 p-trend<0.001 p-trend<0.001 p-trend<0.001
Time since cessation in tertiles (years) <0.001   
 Current smoker 507 25.24 226 14.75 1.00 1.00 1.00
 < 15 273 13.59 185 12.08 0.66 (0.52 - 0.84) 0.68 (0.52 - 0.88) 0.66 (0.50 - 0.87)
15 - 30 203 10.10 180 11.75 0.50 (0.39 - 0.65) 0.52 (0.39 - 0.69) 0.51 (0.37 - 0.69)
≥ 30 126 6.27 160 10.44 0.35 (0.26 - 0.47) 0.40 (0.29 - 0.56) 0.42 (0.30 - 0.60)
Missing 900 44.80 781 50.98 p-trend<0.001 p-trend<0.001 p-trend<0.001
Intensity of smoking cigars in tertiles (cigars per week) <0.001   
 Never-smoker 1471 73.20 1280 83.60 1.00 1.00 1.00
 < 2 26 1.29 38 2.48 0.60 (0.36 - 0.98) 0.50 (0.28 - 0.88) 0.48 (0.27 - 0.87)
 2 - 10 55 2.74 42 2.74 1.14 (0.76 - 1.72) 1.23 (0.80 - 1.89) 1.09 (0.69 - 1.72)
 ≥ 10 40 1.99 31 2.02 1.12 (0.70 - 1.82) 1.12 (0.67 - 1.86) 1.03 (0.60 - 1.77)
Missing 417 20.80 141 9.20 p-trend = 0.771 p-trend = 0.811 p-trend = 0.786
Intensity of smoking pipes in tertiles (pipes per week) <0.001   
 Never-smoker 1467 73.00 1260 82.20 1.00 1.00 1.00
 < 7 48 2.39 48 3.13 0.86 (0.57 - 1.29) 1.07 (0.68 - 1.66) 1.11 (0.69 - 1.78)
 7 - 20 23 1.14 36 2.35 0.55 (0.32 - 0.93) 0.78 (0.44 - 1.38) 0.70 (0.39 - 1.28)
 ≥ 20 31 1.54 42 2.74 0.63 (0.39 - 1.01) 1.23 (0.75 - 2.04) 1.22 (0.72 - 2.07)
Missing 440 21.90 146 9.53 p-trend = 0.005 p-trend = 0.899 p-trend = 0.991
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Mean SD Mean SD p-value1 OR (95%CI) OR (95%CI) OR (95%CI)
Smoking duration (years) 19.00 19.40 15.20 18.50 <0.001 1.01 (1.01 - 1.01) 1.01 (1.01 - 1.01) 1.01 (1.00 - 1.01)
Smoking intensity (cigarettes per day) 12.70 15.60 10.50 15.30 <0.001 1.01 (1.00 - 1.01) 1.01 (1.00 - 1.01) 1.01 (1.00 - 1.01)
Cumulative dose (pack-years) 21.50 32.10 16.50 29.60 <0.001 1.01 (1.00 - 1.01) 1.01 (1.00 - 1.01) 1.00 (1.00 - 1.01)
Time since cessation (years) 10.70 14.00 16.20 16.00 <0.001 0.98 (0.97 - 0.98) 0.98 (0.97 - 0.99) 0.98 (0.97 - 0.99)
Age at smoking initiation (years) 11.00 9.70 9.92 10.30 0.001 1.01 (1.00 - 1.02) 1.01 (1.00 - 1.02) 1.01 (1.00 - 1.02)
Age last smoked (years) 25.10 26.20 21.20 24.90 <0.001 1.01 (1.00 - 1.01) 1.01 (1.00 - 1.01) 1.00 (1.00 - 1.01)
Time of ever quitting (years) 0.68 2.64 0.63 3.82 0.597 1.01 (0.98 - 1.03) 1.00 (0.98 - 1.03) 1.00 (0.98 - 1.03)
Intensity of smoking cigars (cigars per week) 1.03 5.84 0.90 5.18 0.464 1.00 (0.99 - 1.02) 1.00 (0.99 - 1.02) 1.01 (0.99 - 1.03)
Intensity of smoking pipes (pipes per week) 1.06 5.85 1.79 8.27 0.008 0.99 (0.97 - 1.00) 1.00 (0.99 - 1.01) 1.00 (0.99 - 1.02)
PC: pancreatic cancer; ETS: environmental tobacco smoke.
Results are shown for the unimputed smoking variables.
Model 1: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and country (Spain, England, Germany, Ireland, Italy, Sweden). Random effects model applied for country; 
Model 2: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female), country (Spain, England, Germany, Ireland, Italy, Sweden), family history of PC (yes/no) and diabetes (yes/no). 
Random effects model applied for country.
1 Chi-square test applied to evaluate differences between the groups. Significance was set at p<0.05.
2 Type of tobacco was only collected for Spain.
3 Type of pipe was not collected for Ireland.
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Supplementary Table 9. Sensitivity analysis on the association between tobacco smoking and pancreatic cancer risk, excluding 
Italy from the PanGenEU study population (1,476 cases and 1,532 controls).
Model 1
Cases, % Controls, % p-value1 OR (95%CI)
Ever smoked 100 cigarettes <0.001  
No 569 38.60 691 45.10 1.00
 Yes 907 61.40 841 54.90 1.30 (1.11 - 1.53)
Regular smoker <0.001 
 Never-smoker 564 38.20 690 45.00 1.00
 Regular smoker 883 59.80 800 52.20 1.33 (1.13 - 1.57)
 Occasional smoker 29 1.96 42 2.74 1.01 (0.61 - 1.68)
Current smoker <0.001
 Never-smoker 564 38.20 690 45.00 1.00
 Current smoker 271 18.40 231 15.10 1.36 (1.08 - 1.70)
 Former smoker 641 43.40 611 39.90 1.30 (1.10 - 1.55)
Ever quit smoking >6 months 0.001
 Never-smoker 564 38.20 690 45.00 1.00
 Yes 322 21.80 291 19.00 1.35 (1.10 - 1.68)
 No 590 40.00 551 36.00 1.30 (1.09 - 1.55)
Inhalation 0.001
 Never-smoker 564 38.20 690 45.00 1.00
 Mouth only 97 6.57 99 6.46 1.09 (0.80 - 1.50)
 Throat 132 8.94 108 7.05 1.48 (1.11 - 1.99)
 Chest 683 46.30 635 41.40 1.33 (1.12 - 1.58)
p-trend<0.001
Filter-use <0.001
 Never-smoker 564 38.20 690 45.00 1.00
 Filtered only 721 48.80 706 46.10 1.25 (1.06 - 1.48)
 Non-filtered only 56 3.79 49 3.20 1.69 (1.10 - 2.61)
 Both 135 9.15 87 5.68 1.65 (1.21 - 2.26)
p-trend<0.001
Smoking cigar 0.304
 No 1340 90.80 1408 91.90 1.00
 Yes 136 9.21 124 8.09 1.00 (0.76 - 1.32)
Smoking pipe 0.628
 No 1342 90.90 1384 90.30 1.00
 Yes 134 9.08 148 9.66 1.13 (0.86 - 1.48)
Tobacco type for pipe3 0.790
 No pipe smoker 1342 90.90 1384 90.30 1.00
 Black 13 0.88 16 1.04 0.78 (0.37 - 1.66)
 Blond 63 4.27 62 4.05 1.25 (0.85 - 1.82)
 Mixed 58 3.93 70 4.57 1.12 (0.75 - 1.66)
Smoking status (cigarettes) <0.001
 Never-smoker 564 38.20 690 45.00 1.00
 Former 519 35.20 568 37.10 1.14 (0.95 - 1.36)
 Current 393 26.60 274 17.90 1.69 (1.37 - 2.09)
p-trend<0.001
Smoking status incl. occasional <0.001
 Never-smoker 564 38.20 690 45.00 1.00
 Occasional 29 1.96 42 2.74 1.01 (0.61 - 1.67)
 Former 491 33.30 530 34.60 1.14 (0.95 - 1.37)
 Current 392 26.60 270 17.60 1.72 (1.39 - 2.12)
p-trend<0.001
Quit smoking <10 or ≥ 10 years ago <0.001  
 Never-smoker and former smoker quit >10years 567 38.40 410 26.80 1.00
 Current smoker and former smoker quit ≤10years 909 61.60 1122 73.20 0.64 (0.54 - 0.76)
Childhood exposure to ETS <0.001
Both parents were never-smokers 295 20.00 391 25.50 1.00
Only the father smoked 981 66.50 908 59.30 1.25 (1.04 - 1.51)
Only the mother smoked 31 2.10 44 2.87 1.03 (0.62 - 1.71)
Both parents smoked 169 11.40 189 12.30 1.07 (0.81 - 1.42)
p-trend = 0.610
Age at smoking initiation in tertiles (years) 0.001
 Never-smoker 564 38.20 690 45.00 1.00
 < 15 327 22.20 278 18.10 1.36 (1.10 - 1.70)
 15 - 18 317 21.50 299 19.50 1.31 (1.06 - 1.61)
 ≥ 18 268 18.20 265 17.30 1.29 (1.04 - 1.59)
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p-trend = 0.024
Age last smoked in tertiles (years) <0.001  
 Current smoker 393 26.60 274 17.90 1.00
 < 38 147 9.96 198 12.90 0.56 (0.43 - 0.74)
 38 - 50 173 11.70 193 12.60 0.71 (0.55 - 0.94)
 ≥ 50 199 13.50 177 11.60 0.76 (0.58 - 1.01)
Never-smoker 564 38.20 690 45.00 p-trend<0.001
Time of ever quitting in tertiles (years) 0.004
  Current smoker who never quitted 590 40.00 551 36.00 1.00
 < 2 118 7.99 108 7.05 0.93 (0.69 - 1.26)
 2 - 6 93 6.30 86 5.61 0.94 (0.68 - 1.30)
 ≥ 6 111 7.52 97 6.33 1.32 (0.96 - 1.82)
Never-smoker 564 38.20 690 45.00 p-trend = 0.024
Smoking duration in tertiles (years) <0.001
 Never-smoker 564 38.20 690 45.00 1.00
 < 23 202 13.70 284 18.50 0.91 (0.72 - 1.14)
 23 - 35 335 22.70 281 18.30 1.52 (1.23 - 1.87)
 ≥ 35 375 25.40 277 18.10 1.51 (1.23 - 1.85)
p-trend<0.001
Smoking intensity in tertiles (cigarettes per day) <0.001
 Never-smoker 564 38.20 690 45.00 1.00
 < 10 263 17.80 343 22.40 1.02 (0.83 - 1.25)
 10 - 20 369 25.00 287 18.70 1.64 (1.34 - 2.02)
 ≥ 20 280 19.00 212 13.80 1.41 (1.12 - 1.78)
p-trend<0.001
Cumulative dose in tertiles (pack-years) <0.001
 Never-smoker 564 38.20 690 45.00 1.00
 < 14 189 12.80 281 18.30 0.90 (0.72 - 1.13)
 14 - 32 337 22.80 275 18.00 1.57 (1.27 - 1.94)
 ≥ 32 386 26.20 286 18.70 1.50 (1.21 - 1.84)
p-trend<0.001
Time since cessation in tertiles (years) <0.001
 Current smoker 393 26.60 274 17.90 1.00
 < 14 231 15.70 191 12.50 0.81 (0.62 - 1.04)
14 - 28 167 11.30 185 12.10 0.67 (0.51 - 0.88)
≥ 28 121 8.20 192 12.50 0.49 (0.36 - 0.66)
Never-smoker 564 38.20 690 45.00 p-trend<0.001
Intensity of smoking cigars in tertiles (cigars per week) 0.011
 Never-smoker 1280 86.70 1356 88.50 1.00
 < 1.0 69 4.67 68 4.44 0.94 (0.66 - 1.34)
 1.0 - 6.2 44 2.98 48 3.13 0.90 (0.59 - 1.39)
 ≥ 6.2 83 5.62 60 3.92 1.20 (0.84 - 1.73)
p-trend = 0.571
Intensity of smoking pipes in tertiles (pipes per week) 0.384  
 Never-smoker 1306 88.50 1363 89.00 1.00
 < 5.0 67 4.54 58 3.79 1.13 (0.78 - 1.64)
 5.0 - 14.4 61 4.13 53 3.46 1.32 (0.88 - 1.97)
 ≥ 14.4 42 2.85 58 3.79 1.20 (0.78 - 1.85)
p-trend = 0.141
Mean SD Mean SD p-value1 OR (95%CI)
Smoking duration (years) 19.40 19.70 15.20 18.50 <0.001 1.22 (1.12 - 1.33)
Smoking intensity (cigarettes per day) 13.50 16.70 10.50 15.30 <0.001 1.15 (1.06 - 1.25)
Cumulative dose (pack-years) 23.60 35.10 16.50 29.60 <0.001 1.19 (1.09 - 1.30)
Time since cessation (years) 11.00 14.30 16.20 16.00 <0.001 0.75 (0.66 - 0.84)
Age at smoking initiation (years) 10.90 9.79 9.92 10.30 0.008 1.10 (1.02 - 1.19)
Age last smoked (years) 25.70 26.60 21.20 24.90 <0.001 1.18 (1.08 - 1.28)
Time of ever quitting (years) 0.67 2.54 0.63 3.82 0.684 1.01 (0.94 - 1.09)
Intensity of smoking cigars (cigars per week) 1.21 6.42 0.90 5.18 0.165 1.03 (0.95 - 1.12)
Intensity of smoking pipes (pipes per week) 1.23 6.39 1.79 8.27 0.049 1.01 (0.93 - 1.10)
PC: pancreatic cancer; ETS: environmental tobacco smoke.
Results are shown for the categorical, imputed smoking variables, and for the continuous, unimputed smoking variables.
Model 1: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and country (Spain, England, Germany, Ireland, 
Italy, Sweden). Linear associations were assumed for continuous variables. See non-linear associations in Supplementary Table 7.
1 Chi-square test applied to evaluate differences between the groups. Significance was set at p<0.05.
2 Type of tobacco was only collected for Spain.
3 Type of pipe was not collected for Ireland.
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Supplementary Table 10: Baseline characteristics of the PanGenEU study population (2,009 cases and 1,532 controls) 
before imputation.
PanGenEU PanGenEU - Spain
 Cases (%) Controls (%) p-value1 Cases (%) Controls (%) p-value1
Country <0.001 <0.001
 Spain 876 (43.6) 762 (49.7) 876 (100.0) 762 (100.0)
 England 126 (6.3) 22 (1.4) - - - -
 Germany 130 (6.5) 111 (7.3) - - - -
 Ireland 173 (8.6) 290 (18.9) - - - -
 Italy 533 (26.5) 0 (0.0) - - - -
 Sweden 171 (8.5) 347 (22.7) - - - -
Gender 0.313 0.455
 Female 870 (43.3) 701 (45.8) 384 (43.8) 349 (45.8)
 Male 1137 (56.6) 829 (54.1) 492 (56.2) 413 (54.2)
Missing 2 (0.1) 2 (0.1) - - - -
Age <0.001 0.086
≤54 408 (20.3) 261 (17.0) 157 (17.9) 155 (20.3)
55-64 496 (24.7) 320 (20.9) 203 (23.2) 173 (22.7)
65-74 698 (34.7) 494 (32.3) 285 (32.5) 208 (27.3)
≥75 398 (19.8) 454 (29.6) 231 (26.4) 226 (29.7)
Missing 9 (0.5) 3 (0.2) - - - -
BMI (kg/m2) 0.994 0.841
 < 25 757 (37.7) 572 (37.3) 299 (34.1) 262 (34.4)
 25-29.99 773 (38.5) 592 (38.7) 346 (39.5) 295 (38.7)
 ≥ 30 384 (19.1) 293 (19.1) 175 (20.0) 148 (19.4)
Missing 95 (4.7) 75 (4.9) 56 (6.4) 57 (7.5)
Alcohol status2 <0.001 0.009
Never-drinker 565 (28.1) 372 (24.3) 253 (28.9) 243 (31.9) 
Light drinker 601 (29.9) 457 (29.8) 331 (37.8 ) 277 (36.4)
Moderate drinker 413 (20.6) 247 (16.1) 197 (22.5) 129 (16.9) 
Heavy drinker 52 (2.6) 32 (2.1) 12 (1.4) 10 (1.3)
Missing 378 (18.8) 424 (27.7) 83 (9.4) 103 (13.5) 
Family history of PC <0.001 0.001
No 1771 (88.2) 1479 (96.5) 797 (91.0) 729 (95.7)
 Yes 127 (6.3) 40 (2.6) 61 (7.0) 23 (3.0)
Missing 111 (5.5) 13 (0.9) 18 (2.0) 10 (1.3)
Ever been diagnosed with asthma <0.001 0.021
No 1580 (78.6) 1343 (87.7) 790 (90.2) 668 (87.7)
Yes 131 (6.6) 158 (10.3) 59 (6.7) 78 (10.2)
Missing 298 (14.8) 31 (2.0) 27 (3.1) 16 (2.1)
Ever been diagnosed with diabetes <0.001 <0.001
 No 1474 (73.4) 1333 (87.00) 592 (67.6) 620 (81.4)
Yes, ≤ 2 years 200 (9.9) 27 (1.76) 109 (12.4) 20 (2.6)
 Yes, >2 years 263 (13.1) 152 (9.92) 156 (17.8) 109 (14.3)
Missing 72 (3.6) 20 (1.31) 19 (2.2) 13 (1.7)
Ever been diagnosed with chronic pancreatitis <0.001 0.296
No 1885 (93.8) 1507 (98.4) 842 (96.1) 743 (97.5)
Yes 19 (1.0) 2 (0.1) 5 (0.6) 2 (0.3)
Missing 105 (5.2) 23 (1.5) 29 (3.3) 17 (2.2)
BMI: body mass index; PC: pancreatic cancer.
Descriptives are shown for the unimputed baseline characteristics.
1 Chi-square test applied to evaluate differences between the groups. Significance was set at p<0.05.
2 Light drinker: 0-1 drink/day for men and women; Moderate drinker: men: 1-5drinks/day, women: 1-2.5 drinks/day; Heavy drinker: 
  men: ≥5drinks/day, women: ≥2.5 drinks/day.
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Supplementary Table 11. Association between smoking variables and pancreatic cancer risk in the PanGenEU-Spain study population (876 cases and 762 controls) per tobacco type.
Model 1












N % N % OR (95%CI) N % N % OR (95%CI) N % N % OR (95%CI)
Smoking status incl. occasional (cigarettes)
Never-smoker 355 68.30 360 75.90 1.00  355 63.50 360 66.40 1.00  355 70.00 360 77.30 1.00  
Occasional 1 0.19 4 0.84 0.29 (0.03-2.62) 11 1.97 11 2.03 1.18 (0.49-2.81) 2 0.39 2 0.43 1.11 (0.15-8.08)
Former 104 20.00 79 16.70 1.39 (0.95-2.02) 90 16.10 88 16.20 1.18 (0.83-1.67) 76 15.00 58 12.40 1.48 (0.98-2.24)
Current 60 11.50 31 6.54 2.05 (1.25-3.35) 103 18.40 83 15.30 1.55 (1.07-2.24) 74 14.60 46 9.87 1.95 (1.26-3.02)
Smoking intensity in tertiles (cigarettes per day) 
Never-smoker 355 68.30 360 75.90 1.00  355 63.50 360 66.40 1.00  355 70.00 360 77.30 1.00  
< 14 34 6.54 37 7.81 0.99 (0.59-1.66) 82 14.70 81 14.90 1.17 (0.82-1.68) 18 3.55 17 3.65 1.23 (0.61-2.47)
14-25 75 14.40 44 9.28 1.83 (1.18-2.85) 85 15.20 72 13.30 1.46 (1.00-2.14) 31 6.11 17 3.65 2.10 (1.11-3.97)
≥ 25 56 10.80 33 6.96 1.82 (1.11-2.98) 37 6.62 29 5.3 5 1.49 (0.88-2.54) 103 20.30 72 15.50 1.68 (1.15-2.47)
Smoking duration in tertiles (years)  
Never-smoker 355 68.30 360 75.90 1.00  355 63.50 360 66.40 1.00  355 70.00 360 77.30 1.00  
< 26 40 7.69 30 6.33 1.41 (0.83-2.39) 64 11.40 75 13.80 1.07 (0.71-1.59) 32 6.31 30 6.44 1.27 (0.73-2.21)
26-39 54 10.40 35 7.38 1.68 (1.03-2.72) 91 16.30 69 12.70 1.55 (1.07-2.24) 48 9.47 38 8.15 1.53 (0.94-2.49)
≥ 39 71 13.70 49 10.30 1.53 (0.98-2.37) 49 8.77 38 7.01 1.38 (0.86-2.20) 72 14.20 38 8.15 2.11 (1.33-3.36)
Cumulative dose in tertiles (pack-years)  
Never-smoker 355 68.30 360 75.90 1.00  355 63.50 360 66.40 1.00  355 70.00 360 77.30 1.00  
< 18 35 6.73 32 6.75 1.20 (0.70-2.03) 86 15.40 88 16.20 1.18 (0.83-1.68) 17 3.35 18 3.86 1.15 (0.56-2.34)
18-47 68 13.10 44 9.28 1.66 (1.06-2.59) 81 14.50 59 10.90 1.69 (1.14-2.53) 45 8.88 24 5.15 2.15 (1.25-3.70)
 ≥ 47 62 11.90 38 8.02 1.73 (1.08-2.77) 37 6.62 35 6.46 1.17 (0.71-1.94) 90 17.80 64 13.70 1.61 (1.08-2.40)
Age at smoking initiation in tertiles
Never-smoker 355 68.30 360 75.90 1.00  355 63.50 360 66.40 1.00  355 70.00 360 77.30 1.00  
< 15 75 14.40 56 11.80 1.46 (0.95-2.23) 53 9.48 56 10.30 1.21 (0.78-1.87) 65 12.80 50 10.70 1.55 (1.00-2.42)
15 - 18 51 9.81 30 6.33 1.81 (1.09-2.99) 61 10.90 58 10.70 1.28 (0.85-1.93) 55 10.80 36 7.73 1.80 (1.11-2.90)
≥ 18 39 7.50 28 5.91 1.42 (0.83-2.42) 90 16.10 68 12.50 1.43 (1.00-2.06) 32 6.31 20 4.29 1.71 (0.94-3.12)
Age last smoked in tertiles (years)
Current smoker 60 11.50 32 6.75 1.00  104 18.60 85 15.70 1.00  74 14.60 46 9.87 1.00  
< 40 32 6.15 21 4.43 0.82 (0.41-1.66) 30 5.37 36 6.64 0.72 (0.41-1.27) 20 3.94 23 4.94 0.55 (0.27-1.11)
40 - 53 32 6.15 29 6.12 0.59 (0.30-1.15) 32 5.72 27 4.98 0.89 (0.48-1.63) 26 5.13 22 4.72 0.71 (0.36-1.40)
≥ 53 41 7.88 32 6.75 0.67 (0.35-1.29) 38 6.80 34 6.27 0.76 (0.42-1.36) 32 6.31 15 3.22 1.14 (0.54-2.38)
Never-smoker 355 68.30 360 75.90 0.50 (0.31-0.82) 355 63.50 360 66.40 0.66 (0.46-0.95) 355 70.00 360 77.30 0.52 (0.34-0.81)
Inhalation 
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Never-smoker 355 68.30 360 75.90 1.00  355 63.50 360 66.40 1.00  355 70.00 360 77.30 1.00  
Mouth only 21 4.04 16 3.38 1.31 (0.65-2.65) 33 5.90 35 6.46 1.03 (0.62-1.70) 13 2.56 7 1.50 2.05 (0.80-5.29)
Throat 19 3.65 18 3.80 1.10 (0.55-2.16) 36 6.44 25 4.61 1.49 (0.86-2.59) 19 3.75 13 2.79 1.65 (0.78-3.46)
Chest 125 24.00 80 16.90 1.71 (1.18-2.46) 135 24.20 122 22.50 1.40 (1.02-1.94) 120 23.70 86 18.50 1.64 (1.14-2.35)
Filter-use
Never-smoker 355 68.30 360 75.90 1.00  355 63.50 360 66.40 1.00  355 70.00 360 77.30 1.00  
Filtered only 118 22.70 87 18.40 1.45 (1.01-2.07) 194 34.70 171 31.50 1.34 (1.01-1.78) 97 19.10 74 15.90 1.55 (1.06-2.27)
Non-filtered only 7 1.35 6 1.27 1.23 (0.40-3.79) 1 0.18 4 0.74 0.31 (0.03-2.79) 3 0.59 1 0.21 3.10 (0.32-
30.32)
Both 40 7.69 21 4.43 2.08 (1.16-3.75) 9 1.61 7 1.29 1.68 (0.61-4.67) 52 10.30 31 6.65 1.91 (1.14-3.18)
Childhood exposure to ETS
Both parents were 
never-smokers 
104 20.00 111 23.40 1.00  110 19.70 124 22.90 1.00  100 19.70 108 23.20 1.00  
One of the parents 
smoked
405 77.90 350 73.80 1.24 (0.92-1.69) 426 76.20 392 72.30 1.23 (0.92-1.65) 393 77.50 344 73.80 1.24 (0.91-1.68)
Both parents smoked 11 2.12 13 2.74 1.00 (0.42-2.40) 23 4.11 26 4.80 1.20 (0.63-2.28) 14 2.76 14 3.00 1.23 (0.55-2.75)
Time since cessation in tertiles (years)
Current smoker 60 11.50 32 6.75 1.00  104 18.60 85 15.70 1.00  74 14.60 46 9.87 1.00  
< 10 37 7.12 20 4.22 0.98 (0.49-1.96) 46 8.23 45 8.30 0.80 (0.48-1.34) 30 5.92 17 3.65 1.05 (0.52-2.12)
10 - 22 35 6.73 25 5.27 0.75 (0.38-1.47) 33 5.90 30 5.54 0.82 (0.45-1.48) 26 5.13 22 4.72 0.68 (0.34-1.35)
≥ 22 33 6.35 37 7.81 0.47 (0.24-0.90) 21 3.76 22 4.06 0.67 (0.34-1.35) 22 4.34 21 4.51 0.59 (0.29-1.20)
Never-smoker 355 68.30 360 75.90 0.50 (0.31-0.82) 355 63.50 360 66.40 0.65 (0.45-0.94) 355 70.00 360 77.30 0.51 (0.33-0.80)
PC: pancreatic cancer; ETS: environmental tobacco smoke.
Results are shown for the imputed smoking variables.
Model 1: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and region (East, Central and Northern Spain).
1 Chi-square test applied to evaluate differences between the groups per tobacco type. Significance was set at p<0.05.
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Supplementary Table 12. Sensitivity analysis on the association between tobacco smoking and pancreatic cancer risk, in models additionally controlling for smoking duration and 
intensity, for the PC population (2,009 cases and 1,532 controls).
Model 1 Model 1a Model 1b Model 1c Model 1d
OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Ever smoked 100 cigarettes   
No 1.00 1.00 1.00 1.00 1.00
 Yes 1.30 (1.11-1.53) 0.96 (0.72-1.27) 0.87 (0.69-1.11) 0.74 (0.54-1.00) 0.92 (0.71-1.18)
Regular smoker
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Regular smoker 1.33 (1.13-1.57) 1.02 (0.76-1.35) 0.91 (0.71-1.16) 0.78 (0.57-1.07) 0.96 (0.74-1.24)
 Occasional smoker 1.01 (0.61-1.68) 0.86 (0.51-1.45) 0.74 (0.44-1.25) 0.68 (0.40-1.16) 0.83 (0.50-1.40)
Tobacco type2   
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Smoker of black tobacco only 1.55 (1.13 - 2.12) 1.00 (0.72-1.39) 0.93 (0.69-1.25) 0.78 (0.54-1.12) 0.95 (0.70-1.29)
 Smoker of blond tobacco only 1.23 (0.94 - 1.62) 0.97 (0.73-1.30) 0.89 (0.69-1.14) 0.75 (0.55-1.03) 0.93 (0.72-1.20)
 Smoker of both tobacco types 1.58 (1.14 - 2.17) 0.85 (0.56-1.31) 0.88 (0.62-1.23) 0.68 (0.43-1.07) 0.79 (0.54-1.17)
Current smoker
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Current smoker 1.36 (1.08-1.70) 1.02 (0.73-1.41) 0.79 (0.57-1.11) 0.69 (0.47-1.01) 0.91 (0.66-1.26)
 Former smoker 1.30 (1.10-1.55) 0.99 (0.74-1.31) 0.90 (0.71-1.14) 0.77 (0.56-1.05) 0.95 (0.74-1.22)
Ever quit smoking >6 months
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Yes 1.35 (1.10-1.68) 1.03 (0.76-1.40) 0.91 (0.69-1.20) 0.78 (0.56-1.10) 0.98 (0.74-1.30)
 No 1.30 (1.09-1.55) 0.97 (0.72-1.30) 0.89 (0.69-1.14) 0.76 (0.55-1.04) 0.92 (0.71-1.20)
Inhalation
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Mouth only 1.10 (0.80-1.50) 0.89 (0.62-1.28) 0.77 (0.54-1.10) 0.69 (0.47-1.02) 0.86 (0.61-1.22)
 Throat 1.48 (1.11-1.99) 1.15 (0.80-1.66) 1.02 (0.72-1.43) 0.89 (0.60-1.31) 1.09 (0.78-1.54)
 Chest 1.33 (1.12-1.58) 1.00 (0.73-1.35) 0.90 (0.70-1.16) 0.77 (0.55-1.07) 0.93 (0.71-1.23)
Filter-use
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Filtered only 1.25 (1.06-1.48) 0.97 (0.73-1.29) 0.84 (0.66-1.08) 0.74 (0.54-1.01) 0.91 (0.71-1.17)
 Non-filtered only 1.69 (1.10-2.61) 1.33 (0.82-2.15) 1.24 (0.79-1.96) 1.09 (0.66-1.79) 1.29 (0.81-2.04)
 Both 1.65 (1.21-2.27) 1.22 (0.80-1.84) 1.10 (0.76-1.58) 0.93 (0.60-1.44) 1.12 (0.76-1.65)
Smoking cigar
 No 1.00 1.00 1.00 1.00 1.00
 Yes 1.00 (0.76-1.32) 0.92 (0.7-1.21) 0.92 (0.70-1.22) 0.91 (0.69-1.21) 0.92 (0.69-1.21)
Smoking pipe
 No 1.00 1.00 1.00 1.00 1.00 1.00
 Yes 1.13 (0.86-1.49) 1.06 (0.81-1.40) 1.08 (0.82-1.42) 1.07 (0.81-1.41) 1.08 (0.82-1.42)
Tobacco type for pipe3
 No pipe smoker 1.00 1.00 1.00 1.00 1.00
 Black 0.78 (0.37-1.66) 0.77 (0.36-1.65) 0.77 (0.36-1.64) 0.77 (0.36-1.64) 0.77 (0.36-1.65)
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 Blond 1.25 (0.85-1.82) 1.18 (0.81-1.73) 1.16 (0.79-1.70) 1.16 (0.79-1.69) 1.18 (0.80-1.72)
 Mixed 1.12 (0.76-1.66) 1.03 (0.69-1.53) 1.09 (0.73-1.62) 1.08 (0.72-1.60) 1.06 (0.72-1.58)
Smoking status (cigarettes)
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Former 1.14 (0.95-1.36) 0.89 (0.67-1.19) 0.89 (0.70-1.13) 0.76 (0.55-1.03) 0.91 (0.71-1.17)
 Current 1.69 (1.37-2.09) 1.30 (0.95-1.79) 1.19 (0.85-1.66) 1.01 (0.69-1.49) 1.25 (0.92-1.72)
Smoking status incl. occasional
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 Occasional 1.00 (0.61-1.67) 0.87 (0.51-1.47) 0.79 (0.47-1.35) 0.72 (0.42-1.25) 0.87 (0.52-1.46)
 Former 1.14 (0.95-1.37) 0.90 (0.67-1.21) 0.90 (0.71-1.15) 0.77 (0.56-1.05) 0.92 (0.71-1.19)
 Current 1.72 (1.39-2.12) 1.33 (0.97-1.84) 1.22 (0.87-1.70) 1.05 (0.71-1.54) 1.28 (0.93-1.77)
Quit smoking <10 or ≥ 10 years ago
 Never-smoker and former smoker quit >10years 1.00 1.00 1.00 1.00 1.00
 Current smoker and former smoker quit ≤10years 0.64 (0.54-0.76) 0.70 (0.57-0.85) 0.75 (0.58-0.97) 0.75 (0.58-0.97) 0.73 (0.59-0.91)
Childhood exposure to ETS
Both parents were never-smokers 1.00 1.00 1.00 1.00 1.00
Only the father smoked 1.25 (1.04-1.51) 1.20 (1.00-1.45) 1.20 (0.99-1.44) 1.19 (0.99-1.44) 1.20 (0.99-1.44)
Only the mother smoked 1.02 (0.62-1.70) 0.97 (0.58-1.62) 0.96 (0.58-1.60) 0.96 (0.57-1.60) 0.96 (0.58-1.61)
Both parents smoked 1.07 (0.81-1.42) 1.01 (0.76-1.34) 1.01 (0.76-1.34) 1.00 (0.75-1.33) 1.01 (0.76-1.34)
Age at smoking initiation in tertiles (years)
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 < 15 1.36 (1.10-1.70) 1.00 (0.71-1.40) 0.88 (0.65-1.19) 0.73 (0.50-1.07) 0.90 (0.65-1.25)
 15 - 18 1.31 (1.06-1.61) 0.99 (0.72-1.35) 0.89 (0.68-1.17) 0.75 (0.54-1.06) 0.93 (0.70-1.24)
 ≥ 18 1.29 (1.04-1.59) 1.00 (0.74-1.35) 0.91 (0.69-1.18) 0.78 (0.56-1.08) 0.96 (0.73-1.26)
Age last smoked in tertiles (years)
 Current smoker 1.00 1.00 1.00 1.00 1.00
 < 38 0.56 (0.43-0.74) 0.58 (0.44-0.76) 0.75 (0.50-1.13) 0.73 (0.48-1.10) 0.64 (0.47-0.86)
 38 - 50 0.71 (0.55-0.93) 0.72 (0.55-0.95) 0.78 (0.57-1.07) 0.77 (0.56-1.05) 0.75 (0.57-0.99)
 ≥ 50 0.76 (0.58-1.01) 0.77 (0.58-1.01) 0.73 (0.55-0.97) 0.74 (0.56-0.98) 0.77 (0.58-1.01)
Never-smoker - - - - - - - - - -
Time of ever quitting in tertiles (years)
  Current smoker who never quitted 1.00 1.00 1.00 1.00 1.00
 < 2 0.93 (0.69-1.26) 0.94 (0.69-1.27) 0.92 (0.68-1.24) 0.92 (0.68-1.25) 0.93 (0.69-1.26)
 2 - 6 0.94 (0.68-1.30) 0.97 (0.69-1.35) 0.88 (0.63-1.22) 0.90 (0.64-1.25) 0.95 (0.68-1.32)
 ≥ 6 1.32 (0.96-1.82) 1.36 (0.98-1.87) 1.35 (0.97-1.86) 1.37 (0.99-1.89) 1.37 (0.99-1.88)
Never-smoker - - - - - - - - - -
Smoking duration in tertiles (years)
 Never-smoker 1.00 1.00 - - - - 1.00
 < 23 0.91 (0.72-1.14) 0.75 (0.55-1.03) - - - - 0.82 (0.63-1.07)
 23 - 35 1.52 (1.23-1.87) 1.24 (0.91-1.69) - - - - 1.28 (0.94-1.74)
 ≥ 35 1.51 (1.23-1.86) 1.20 (0.86-1.67) - - - - 1.19 (0.82-1.74)
Smoking intensity in tertiles (cigarettes per day)   
 Never-smoker 1.00 - - 1.00 - - 1.00
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 < 10 1.02 (0.83-1.25) - - 0.76 (0.58-0.98) - - 0.83 (0.63-1.08)
 10 - 20 1.64 (1.34-2.02) - - 1.15 (0.87-1.52) - - 1.13 (0.78-1.64)
 ≥ 20 1.41 (1.12-1.78) - - 0.96 (0.70-1.31) - - 0.78 (0.46-1.34)
Cumulative dose in tertiles (pack-years)
 Never-smoker 1.00 1.00 1.00 1.00 - -
 < 14 0.90 (0.72-1.13) 0.90 (0.66-1.22) 0.78 (0.60-1.01) 0.70 (0.48-1.01) - -
 14 - 32 1.57 (1.27-1.94) 1.56 (1.08-2.26) 1.19 (0.88-1.62) 1.00 (0.60-1.66) - -
 ≥ 32 1.50 (1.21-1.84) 1.49 (0.90-2.45) 1.05 (0.72-1.52) 0.80 (0.39-1.64) - -
Time since cessation in tertiles (years)   
 Current smoker 1.00 1.00 1.00 1.00 1.00
 < 14 0.81 (0.63-1.04) 0.81 (0.62-1.05) 0.80 (0.62-1.04) 0.82 (0.63-1.06) 0.81 (0.63-1.04)
14 - 28 0.68 (0.51-0.89) 0.68 (0.50-0.94) 0.68 (0.49-0.92) 0.70 (0.53-0.93) 0.68 (0.51-0.89)
≥ 28 0.51 (0.38-0.69) 0.54 (0.36-0.82) 0.54 (0.36-0.81) 0.55 (0.39-0.76) 0.51 (0.38-0.69)
Never-smoker - - - - - - - - - -
Intensity of smoking cigars in tertiles (cigars per week)
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 < 1.0 0.95 (0.67-1.34) 0.94 (0.66-1.34) 0.92 (0.65-1.31) 0.92 (0.65-1.31) 0.94 (0.66-1.34)
 1.0 - 6.2 0.91 (0.59-1.39) 0.81 (0.52-1.25) 0.83 (0.54-1.28) 0.82 (0.53-1.27) 0.81 (0.52-1.25)
 ≥ 6.2 1.20 (0.84-1.73) 1.11 (0.77-1.60) 1.13 (0.78-1.62) 1.12 (0.77-1.61) 1.11 (0.77-1.60)
Intensity of smoking pipes in tertiles (pipes per week)
 Never-smoker 1.00 1.00 1.00 1.00 1.00
 < 5.0 1.13 (0.78-1.64) 1.14 (0.78-1.66) 1.15 (0.79-1.68) 1.15 (0.79-1.68) 1.15 (0.79-1.68)
 5.0 – 14.4 1.32 (0.89-1.97) 1.21 (0.81-1.82) 1.24 (0.83-1.86) 1.23 (0.82-1.85) 1.22 (0.82-1.83)
 ≥ 14.4 1.20 (0.78-1.85) 1.13 (0.73-1.75) 1.15 (0.75-1.79) 1.15 (0.74-1.78) 1.15 (0.74-1.78)
Smoking duration (years) 1.01 (1.01-1.01) 1.17 (1.04-1.33) - - - - 1.10 (0.93-1.29)
Smoking intensity (cigarettes per day) 1.01 (1.00-1.01) - - 1.02 (0.93-1.12) - - 0.82 (0.69-0.98)
Cumulative dose (pack-years) 1.01 (1.00-1.01) 1.08 (0.93-1.26) 1.05 (0.94-1.17) 1.06 (0.9-1.24) - -
Time since cessation (years) 0.98 (0.97-0.99) 0.76 (0.67-0.85) 0.86 (0.71-1.05) 0.86 (0.71-1.04) 0.78 (0.68-0.89)
Age at smoking initiation (years) 1.01 (1.00-1.02) 0.98 (0.88-1.08) 0.95 (0.86-1.04) 0.92 (0.83-1.03) 0.97 (0.89-1.07)
Age last smoked (years) 1.01 (1.00-1.01) 1.05 (0.95-1.15) 1.01 (0.92-1.11) 1.00 (0.90-1.11) 1.02 (0.93-1.13)
Time of ever quitting (years) 1.00 (0.98-1.03) 0.99 (0.92-1.08) 0.99 (0.91-1.07) 0.99 (0.91-1.07) 0.99 (0.92-1.08)
Intensity of smoking cigars (cigars per week) 1.00 (0.99-1.02) 1.01 (0.94-1.10) 1.02 (0.94-1.10) 1.02 (0.94-1.10) 1.01 (0.94-1.09)
Intensity of smoking pipes (pipes per week) 1.00 (0.99-1.01) 1.00 (0.92-1.08) 1.00 (0.93-1.09) 1.00 (0.93-1.09) 1.00 (0.92-1.09)
PC: pancreatic cancer; ETS: environmental tobacco smoke.
Results are shown for the categorical, imputed smoking variables, and for the continuous, unimputed smoking variables.
Model 1: adjusted for age (≤ 54, 55-64, 65-74, ≥75 years), gender (male, female) and country (Spain, England, Germany, Ireland, Italy, Sweden); 
Model 1a: Model 1 plus additional adjustment for smoking intensity (cigarettes per day, continuous, non-linear); 
Model 1b: Model 1 plus additional adjustment for smoking duration (years, continuous, non-linear); 
Model 1c: Model 1 plus additional adjustment for smoking intensity (cigarettes per day, continuous, non-linear) and smoking duration (years, continuous, non-linear); 
Model 1d: Model 1 plus additional adjustment for cumulative dose (pack-years, continuous, non-linear).
1 Chi-square test applied to evaluate differences between the groups. Significance was set at p<0.05.
2 Type of tobacco was only collected for Spain.
3 Type of pipe was not collected for Ireland.
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Supplementary Table 13: Combined effects of smoking intensity and duration in the PanGenEU study 
population (2,009 cases and 1,532 controls).
Cases (%) Controls (%) Model 1
OR (95% CI)
Never smokers 759 (37.8) 690 (45.0) 1.00 (Ref.)
Low intensity & high duration 120 (6.0) 79 (5.2) 1.18 (0.84-1.13)
Moderate intensity & high duration 182 (9.1) 102 (6.7) 1.54 (1.15-2.07)
High intensity & high duration 179 (8.9) 96 (6.3) 1.78 (1.32-2.39)
Low intensity & moderate duration 141 (7.0) 118 (7.7) 1.18 (0.87-1.61)
Moderate intensity & moderate duration 241 (12.0) 96 (6.3) 2.25 (1.67-3.02)
High intensity & moderate duration 95 (4.7) 67 (4.4) 1.18 (0.81-1.70)
Low intensity & low duration 128 (6.4) 146 (9.5) 0.78 (0.58-1.06)
Moderate intensity & low duration 110 (5.5) 89 (5.8) 1.08 (0.76-1.54)
High intensity & low duration 54 (2.7) 49 (2.7) 1.01 (0.65-1.58)
Model 1: adjusted for age, sex and country.
Low, moderate and high levels of smoking intensity and smoking duration were based on tertiles, as reported in the article.
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Figure 1 (A-G): Dose-response relationships between several smoking variables and the risk of PC, depicted by restricted cubic splines with knots at 10%, 50% and 90%, 
represented as dashed, vertical lines. Not adjusted for age, gender and country (for the PanGenEU study population) or region (for the PanGenEU-Spain study population) or 
smoking intensity or duration. Splines are shown for the unimputed data. The spline curve with smoothing applied is shown as a black trend line, the original spline curve is 
shown as a reference in grey. The dashed horizontal black line represents the reference odds ratio of 1.
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